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Table 6.3S Case-control studies on smoking and primary liver cancer
Study Design/population Findings (95% CI)a Comments
Trichopoulos 





•	Ever smoker: 5.5 (2.0–15.6) among HBV 
negatives
•	Cigarettes/day (within 5 years of diagnosis):
 – 1–10: 1.3
 – 11–20: 2.5b
 – 21–30: 3.7b
 – ≥31: 8.4b
Association confined to 
persons who were HBV 
negative; effect persisted 
after adjusting for alcohol 
consumption 






•	Ever smoker: 1.3 (0.7–2.4)
 – 1–19 cigarettes/day: 1.0 (0.5–10.7)
 – ≥20 cigarettes/day: 1.5 (0.8–2.8)
•	HBsAg positive: 0.3 (0.1–1.4)
•	HBsAg negative: 2.9 (0.8–10.7)
Association confined to 
persons who were HBV 








•	Ever smoker, men: 0.7 (0.5–1.1)
•	Ever smoker, women: 1.0 (0.6–1.7) 
Adjusted for age; no 
difference when adjusted for 
alcohol consumption ; no 
dose-response association




•	Current smokers compared with never and 
long-term former smokers:
 – ≤20 cigarettes/day: 1.2 (0.6–2.5)
 – >20 cigarettes/day: 2.6 (1.0–6.7)
 – Former smokers: 1.1 (0.3–4.0) 
In stratified analyses, 
significant risk observed 
only among those with 
both heavy smoking (>20 
cigarettes/day) and heaviest 
consumption of alcohol 
(>80 g/day) 
Hardell et al. 
1984 
•	83 cases (men who died of 
primary liver cancer or liver 














•	360 controls (hospitalized 
patients with cirrhosis, other 
tumors, or with diagnoses 
other than those 2)
•	1980–1984
•	 Italy
•	Current smoker: 0.9 (CI not reported)
•	HCC compared with noncirrhosis, noncancer 
controls: 0.8 (0.4–1.5)
Compared HCC cases with 
3 control groups; estimates 
are unadjusted





•	<1.0 for any smoking and also for ≥20 
cigarettes/day (CI not reported)
•	Among HBV negatives, OR = 1.25 for ever 
smokers 
Controls matched for age, 
race, gender, recruitment 
site, and urban/rural 
background 





•	Ever smoker: 1.1 (0.5–2.4)
•	Current smoker: 1.6 (0.7–3.7)
•	Cigarettes/day among current smokers:
 – <20: 1.7
 – ≥20: 1.2
Controls matched for age, 
gender, race, and residence; 
adjusted for consumption 
of alcohol; HBsAg negative 
only
Surgeon General’s Report
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Trichopoulos 








Association confined to 
persons who were HBV 
negative






•	Former smoker: 0.6 (0.4–1.0)
•	Current smoker: 0.9 (0.6–1.5)
Adjusted for age, gender, 
geographic area, hepatitis, 
cirrhosis, and consumption 
of alcohol; no dose-response 
relationship for cigarette 
smoking





 – Unadjusted OR = 1.1 (0.7–1.8)
 – Adjusted OR = 1.33 for smokers 
–– χ2 for trend = 0.88 (p >0.05) 
Adjusted for gender 
and HBsAg status; in 
multivariate analysis, 
smoking behaviors 
(duration in years, and 
number of cigarettes 
smoked/day) were not 
associated with HCC 




•	3.3; p <0.05 Association limited to 
current-smoking females 









•	Cigarettes/day (findings not significant):
 – <15: 0.9
 – 15–24: 0.7
 – ≥25: 0.8
Adjusted for age, gender, 
consumption of alcohol, 
education level, marital 
status, and coffee 
consumption







 – <20: 1.0 (baseline)
 – 20–39: 1.9 (1.1–3.3)
 – 40–59: 2.0 (1.1–3.6)
 – ≥60: 1.0 (0.5–1.9)
Adjusted for HBsAg status, 
age, gender, consumption of 
alcohol, and family history 
of liver cancer





•	Ever smoker: 2.2 (0.8–6.1) Adjusted for age and 









 – 1–20: 1.4
 – >20: 1.1
No association based on 
unadjusted data or after 











 – All: 1.7 (0.9–3.1) 
 – Men: 1.5 (0.8–2.8)
 – Women: 7.1 (0.7–26.5)
Unadjusted
Table 6.3S Continued
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•	Former smoker: 0.7 (0.3–1.9)
•	Current smoker: 2.5 (1.4–4.5)
•	Cigarette index (lifetime number of cigarettes):
 – 0–399: Reference
 – 400–799: 1.7 (1.0–2.8)
 – 800–1,199: 1.8 (1.0–3.1)
 – >1,200: 1.0 (0.5–1.8)
Adjusted for age and gender; 
index adjusted for HBsAg, 
history of transfusion, and 
family history 







 – 1–10: 1.1 (0.6–2.0) [1.05]
 – 11–20: 1.9 (1.2–3.1) [1.48]
 – ≥21: 3.0 (1.5–5.8) [2.62]
Adjusted for consumption 
of alcohol, HBsAg/HBeAg 
status, family history of 
HCC, gender, age, ethnic 








•	Former smoker: 0.6 (0.4–1.2)
•	Current smoker: 1.0 (0.7–1.6)
•	Cigarettes/day:
 – 1–20: 1.2 (0.8–1.8)
 – 21–40: 0.6 (0.3–1.2)
 – ≥41: 0.5 (0.1–2.6)
•	Duration (years):
 – 1–19: 0.7 (0.4–1.3)
 – 20–39: 1.0 (0.6–1.6)
 – ≥40: 1.9 (0.4–1.8)
Adjusted for age, marital 
status, education level, 
consumption of alcohol, and 
HBV status
Lin et al. 1991 •	200 cases (HBV-negative 
males without alcoholic 
cirrhosis in an aflatoxin-




•	Ever smoker: 0.6 (0.4–1.0) Included only men because 







•	Current smokers compared with never and 
occasional smokers: 1.0 (0.4–2.4) 
•	HBV negative: 1.8 (0.5–5.9)
Unadjusted estimates; 
smoking not included in 
multivariate models






•	HCC cases with cirrhosis: 2.3 (0.9–5.9)
•	HCC cases without cirrhosis: 2.1 (1.1–4.0)
•	HBsAg-positive cases and controls: 1.7 (0.5–
5.6)
•	HBsAg-negative cases and controls: 2.4 
(1.2–4.7)
Adjusted for age, gender, 
and HBsAg/HCV status





 – Former smoker: 1.6 (0.7–3.5)
 – Current smoker: 2.5 (1.2–5.0)
•	Adjusted for consumption of alcohol:
 – Former smoker: 1.1 (0.4–2.6)
 – Current smoker: 2.1 (1.1–4.3)
Table 6.3S Continued
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 – 1–10: 1.1 (0.5–2.2)
 – 11–20: 1.8 (1.0–3.4)
 – >20: 1.7 (0.7–4.5)
•	Cigarettes/day (adjusted for HBV, HCV, 
consumption of alcohol, and peanut 
consumption):
 – 1–10: 0.4 (0.1–1.9)
 – 11–20: 1.3 (0.4–4.2)
 – >20: 2.1 (0.3–13.5)
Matched OR; adjusted for 
HBV, HCV, consumption 








 – 0–19, Men: 2.2 (0.3–6.3)
 – 0–19, Women: 1.3 (0.5–3.4)
 – ≥20, Women: 0.7 (0.2–2.5)
Adjusted for consumption of 
alcohol, age, and HBV status






•	Ever smoker: 1.8 (0.6–5.6) Adjusted for age, education 
level, residence, aflatoxin 
exposure, consumption of 
alcohol, and HBsAg; males 
only






•	Current smokers: 1.5 (0.8–2.7)
•	Former smokers: 1.5 (0.8–2.8)
Adjusted for age, gender, 
consumption of alcohol, 
HBsAg status, history of 
blood transfusion, and 
family history of liver 
disease; there was no 
significant trend in risk with 
years smoked 






•	Current smoker with >40 pack-years: 1.2 
(0.5–2.9)
Adjusted for consumption 
of alcohol and HBV/ HCV 
status







 – 1–20: 0.7 (0.2–2.4)
 – >20: 0.4 (0.1–1.6)
Adjusted for age, gender, 
HBV/HCV status, history 
of blood transfusion, and 
consumption of alcohol






•	Ever smoker: 1.6 (0.9–2.0) Adjusted for age, gender, 
alcohol abuse, HBV/HCV 
status; HBsAg by smoking 





•	2,238 controls (had cancer 
at sites not previously 




•	Ever smoker: 0.9 (0.4–2.1)
•	Pack-years:
 – <25: 1.4 (0.5–3.8)
 – 25–49: 0.7 (0.3–1.9)
 – 50–74: 0.7 (0.2–2.2)
 – ≥75: 0.8 (0.3–2.7)
Adjusted for age; men, 
35–70 years of age only
Table 6.3S Continued
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•	Current smoker: 1.8 (0.9–3.4)
•	Former smoker: 2.8 (1.1–6.9)
•	Ever smoker, male: 1.9 (1.2–2.8)
•	Pack-years:
 – 0.1–12.9: 2.4 (1.1–4.9)
 – ≥13.0: 1.8 (0.8–3.7)
Adjusted for age, study 
category (except for ever 
smokers), HBV status, 
history of blood transfusion, 
family history of liver 
cancer, and consumption of 
alcohol; combined analysis 
of 3 studies; partial overlap 
with Tanaka et al. (1992) 






•	Current smoker, moderate level: 2.3 (0.4–11.7)
•	Current smoker, high level (>20 cigarettes/day 
for >10 years): 1.1 (0.3–2.5)
Adjusted for HBV/HCV 
status, history of Clonorchis 
sinensis, history of 
hepatitis, other liver disease, 
consumption of alcohol, 
and SES






•	≥5 pack-years vs. <5 pack-years: 3.3 (1.3–8.3)
•	≥10 pack-years vs. <10 pack-years: 3.3 (1.3–
8.3)
 






•	Ever smoker: 5.4 (1.1–27) Adjusted for age, gender, 
HBV/HCV infection, and 
CYP2E1 genotype







 – Former smoker: 1.2 (0.7–1.9)
 – Current smoker: 1.5 (0.7–3.0)
 – Ever smoker: 1.6 (0.8–2.9)
•	≥40 cigarettes/day: 
 – Former smoker: 1.2 (0.8–1.9)
 – Current smoker: 1.6 (0.9–2.9)
 – Ever smoker: 2.5 (1.1–5.5)
Adjusted for age, gender, 








•	Current smokers: 1.6 (0.7–3.5)
•	Former smokers: 0.7 (0.3–1.5)
Adjusted for age and 
consumption of alcohol; 
males only







 – 35–69 years of age: 1.6 (1.3–1.9)
 – ≥70 years of age: 1.2 (0.9–1.5)
•	Ever smoker, women:
 – 35–69 years of age: 1.4 (0.8–2.4)
 – ≥70 years of age: 1.4 (0.9–2.0)
Adjusted for age and 
education level
Hassan et al. 
2002
•	115 cases
•	230 hospital-based controls 
with cancer of skin and GI, 




•	Current smoker: 1.2 (0.6–2.4) Controls were matched 
on age, gender, and 
recruitment date; adjusted 
for diabetes, consumption of 
alcohol, HBV, and HCV
Table 6.3S Continued
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•	Ever smokers: 0.7 (0.3–1.7) Adjusted for age, gender, 
residence, and HBV 
infection
Chen et al. 
2003
•	36,000 cases (liver cancer 
deaths)





 – Ever smoker: 1.4 (1.3–1.4)
 – 10 cigarettes/day: 1.3
 – 20 cigarettes/day: 1.5
 – 30 cigarettes/day: 1.6
•	Women:
 – Ever smoker: 1.2 (1.1–1.3)
 –  <20 cigarettes/day: 1.1
 – ≥20 cigarettes/day: 1.5 
Controls were indirectly 
controlled for HBV infection 
and consumption of alcohol; 
adjusted for age and locality; 
RR independent of age, 
urban/rural status, or age at 
start of smoking 





•	Former smoker: 2.5 (1.2–5.0)
•	Current smoker: 2.4 (0.9–6.4)
Unadjusted estimates




•	Cumulative cigarette smoking (pack-years):
 – Male: 1.05 (0.82–1.36)
 – Female: 1.80 (0.40–8.14)
Adjusted for history of blood 
transfusion, consumption of 
alcohol, and diabetes 






•	Ever smoker: 1.2 (0.6–2.7) Adjusted for age and gender






•	Smoking index (lifetime number of cigarettes): 
1.2 (0.8–1.9)
Controlled for consumption 
of alcohol and HBV 
infection




based in; included never 
smokers and recent ex-
smokers)
•	1984–2002
•	Los Angeles County, 
California
•	Current or recent exsmokers compared with 
never smokers or long-term exsmokers: 1.6 
(1.1–2.2)
•	Cigarettes/day:
 – 1–20: 1.5 (1.0–2.5)
 – >20: 1.6 (1.1–2.4)
•	HBV negative and HCV negative: 1.7 (1.0–3.0)
Exsmokers defined as those 
who quit within the last 
10 years; adjusted for age, 
gender, race, education 
level, consumption of 
alcohol, and diabetes; no 
clear interaction between 
smoking and consumption 
of alcohol, diabetes, or HBV/
HCV







 – <20: 0.9 (0.5–1.7)
 – ≥20: 0.7 (0.4–1.2)
Adjusted for HBV, HCV, and 
consumption of alcohol
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Marrero et al. 
2005 
•	70 cases
•	140 controls (included non-




•	Smoking status (compared with healthy 
controls):
 – Current smokers: 10.9 (3.5–34.0)
 – Ever smokers: 12.3 (4.4–34.2)
 – Former smokers: 13.3 (4.5–38.9)
•	Pack-years (compared with healthy controls):
 – <20: 1.2 (0.7–1.5)
 – ≥20: 63.7 (17–144)
•	Pack-years (compared with cirrhotic controls):
 – <20: 0.7 (0.4–1.2)
 – ≥20: 4.9 (2.2–10.6)
Not adjusted for current, 
ever, or former smoking 
effects; estimates for pack-
years adjusted for race, 








•	Current smokers: 1.1 (0.6–2.2)
 – 1–14 cigarettes/day: 1.2 (0.6–2.4)
 – ≥15 cigarettes/day: 1.1 (0.5–2.5)
•	HBsAg positive or anti-HCV positive: 44.3 
(19.7–99.3)
•	HBsAg negative and anti-HCV negative: 1.0 
(0.5–2.0)
•	Former smokers: 0.8 (0.4–1.5)
Adjusted for age, gender, 
education level, HBV and 
HCV infections; when 
stratified by HBV/HCV 
infection, no association of 
smoking and HCC among 
those who were negative, 
strong association among 
positive






•	Former smokers: 1.9 (1.1–3.3)
•	Current smokers: 1.5 (0.8–2.7)
•	Packs/day (OR): 
 – <1: 1.4 (0.7–2.7)
 – 1–2: 1.7 (0.9–3.0)
 – >2: 1.8 (0.9–3.8)
 – p trend = 0.068 
Adjusted for demographics, 
SES, consumption of 
alcohol, and detailed 
medical history; risk 
estimates similar but less 
precise for HCC only; males 
only
Hara et al. 
2008 
•	209 cases
•	256 hospital controls and 





 – Former smokers: 0.8 (0.3–2.3)
 – Current smokers: 1.8 (0.6–5.1)
•	Chronic liver disease controls:
 – Former smokers: 1.0 (0.6–1.7)
 – Current smokers: 2.5 (1.4–4.6)
Adjusted for age, gender, 
HBV, HCV, and consumption 
of alcohol; no dose-response 
association with intensity 
or pack-years of smoking; 
recent heavy exposure 
appeared to be associated 
most with risk among 
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•	Ever smokers, both genders: 1.5 (1.0–2.1)
•	Ever smokers, men: 1.9 (1.2–3.1)
 – HCV positive: 136.3 (43.2–429.0)
 – HCV negative: 1.8 (1.1–2.9)
 – HBsAg1 positive or anti-HBc13 positive: 9.6 
(3.9–22.4)
 – HBsAg1 negative and anti-HBc13 negative: 
2.0 (1.2–3.3)
•	Ever smokers, women: 1.1 (0.5–1.8)
 – HCV negative: 1.2 (0.6–2.0)
 – HBsAg1 positive or anti-HBc13 positive: 6.7 
(1.9–24.1)
 – HBsAg1 negative and anti-HBc13 negative: 
1.1 (0.6–1.9)
•	Former smokers, all: 1.4 (0.9–2.1)
•	Former smokers, men:
 – Quit <10 years: 2.4 (1.2–4.9)
 – Quit ≥10 years: 1.7 (0.9–2.8)
Adjusted for age, race, 
education level, marital 
status, state of residency, 
HCV, HBV, diabetes, heavy 
consumption of alcohol, 
and family history of cancer; 
significant risk (without 
dose-response relationship) 
also observed for intensity, 
duration, and pack-years 
of smoking for men, 
nonsignificant for women; 
protective associations 
tended to be observed for 
noncigarette tobacco use 
and for passive exposure to 
smoke






•	Ever smoker (OR): 1.8 (1.3–2.4)
 – ≤20 pack-years (OR): 1.4 (0.9–2.1)
 – >20 pack-years (OR) = 2.0 (1.4–2.9)
Extension of study by 
Hassan and colleagues 
(2008); adjusted for age, 
gender, race, education 
level, HBV, HCV, 
consumption of alcohol, 
diabetes, and family history 
of liver cancer






•	Ever smoker, unadjusted: 2.3 (1.5–3.5)
•	Compared with nonsmokers who were negative 
for viral hepatitis:
 – Smokers without viral hepatitis had an 
increased risk for HCC: 44.4 (17.8–116)
 – Smokers with viral hepatitis had an 
increased risk for HCC: 90 (32.1–266)
Performed interaction 
analysis of smoking and 
viral hepatitis (HBsAg or 
anti-HCV); adjusted for age 
and gender 






•	Ever smoker: 1.4 (0.7–2.8):
 – Moderate use: 1.8 (0.8–4.5)
 – Heavy use: 1.7 (0.8–3.7)
Adjusted for age, gender, 
and HBV/HCV status
Wan et al. 
2011 
•	Asian immigrant patients 
with chronic HBV infection 
who were recruited from a 
single hospital site 
•	44 early-onset and 124 late-
onset cases




•	Early onset of HCC among ever smokers: 3.4 
(1.5–8.0)
•	No significant association between smoking 
and late onset of HCC in adjusted model
Early onset defined as males 
<40 years of age and females 
<50 years of age; adjusted 
for gender, cirrhosis, and 
family history of HCC
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Ha et al. 2012 •	Hospital-based case-control 
study 
•	259 cases




•	Lifetime tobacco use >11,000 packs: 1.7 
(1.0–2.9)
Adjusted for race, age, 
gender, cirrhosis, level 
of alpha-fetoprotein, 
consumption of alcohol, 
diabetes, and etiology of 
liver disease (including HBV 
and HCV)






•	Current smoker: 1.5 (0.8–2.7) Adjusted for location, 
gender, age, birthplace, 
education level, HCV, 
HBV, heavy consumption 
of alcohol, diabetes, and 
obesity
Notes: AOR = adjusted odds ratio; CI = confidence interval; g = gram; GI = gastrointestinal; HBc13 = hepatitis B core antibody; 
HBeAG = hepatitis B e antigen; HBsAg = hepatitis B surface antigen; HBV = hepatitis B virus; HCC = hepatocellular carcinoma; HCV 
= hepatitis C virus; OR = odds ratio; pack-years = the number of years of smoking multiplied by the number of packs of cigarettes 
smoked per day; RR = relative risk; SES = socioeconomic status. 
aFindings are reported as RRs in comparisons with never smokers unless indicated otherwise.
bResults significantly higher than 1.00.
Table 6.3S Continued
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 – Men 1.5 (p = 0.01)
 – Women 2.6 (p = 0.001)
•	Current smoker:
 – Men: 1.3
 – Women: 1.9 (p = 0.01)
Adjusted for age
Oshima et al. 
1984 








 – >30: 5.8 (1.0–34.2)
 – ≤30: 1.7 (0.4–6.4)
Tu et al. 1985 •	HBV-positive cohort




•	HBV carrier, mortality rate:
 – Nonsmoker: 332.8
 – Current smoker: 737.9
 – ≤19 cigarettes/day: 660.1
 – ≥20 cigarettes/day: 1,519 (p <0.05)
•	HBV noncarrier, mortality rate:
 – Nonsmoker: 115.1
 – Current smoker: 99.9
 – ≤19 cigarettes/day: 96.3
 – ≥20 cigarettes/day: 145.2
Adjusted for age and consumption 
of alcohol
Shibata et al. 
1986 
•	Nested case-control study 





•	1–19 cigarettes/day: 2.0 (0.4–9.8)
•	≥20 cigarettes/day: 1.8 (0.4–8.9)











 – 1–7: 1.6
 – 8–15: 3.3
 – >15: 4.1
Relative death rates standardized 
for age and residence; χ2 test for 
trend of cigarettes/day reported as 
significant





•	Ever smokers compared with never and 
occasional smokers:
 – 1–19 cigarettes/day: 1.1 (0.6–2.2)
 – ≥20 cigarettes/day: 1.0 (0.5–2.2)
•	Current and past smokers compared 
with never and occasional smokers:
 – 1–19 cigarettes/day: 1.1 (0.6–2.2)
 – ≥20 cigarettes/day: 1.0 (0.5–2.2)
Adjusted for age and consumption 
of alcohol





•	Current smoker: 3.1 (1.8–5.4)
•	Cigarettes/day: 
 – 1–29: 3.1 (1.8–5.4)
 – >30: 6.8 (3.6–13.1)
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Hiyama et al. 
1990




•	Ratio of observed/expected: 1.4 (1.1–1.7)  
Hiyama et al. 
1990
•	Nested case-control study 





 – Crude OR: 1.7 (0.4–6.4)
 – Adjusted OR: 1.2
•	≥30 cigarettes/day:
 – Crude OR: 5.8 (1–34.2)
 – Adjusted OR: 6.3
Controls matched by age; AOR 




•	122,261 (men) and 
142,857 (women) followed





 – Men: 1.5 (1.2–1.9)
 – Women: 1.6 (1.2–2.0) 
•	Cigarettes/day, men:
 – 1–4: 1.1 (0.5–2.0)
 – 5–14: 1.6 (1.3–2.0)
 – 15–24: 1.4 (1.2–1.8)
 – 25–34: 1.6 (1.1–2.4)
 – ≥35: 1.9 (1.1–3.2)
 – p trend = 0.002
•	Cigarettes/day, women:
 – 1–4: 1.4 (0.7–2.5)
 – 5–14: 1.4 (1.0–2.0)
 – ≥15: 2.5 (1.3–4.1)
 – p trend = 0.001
Adjusted for prefecture, 
occupation, age, and observation 
period; no trend in risk observed 
in relation to calendar period
Hsing et al. 
1990






•	Current smokers: 2.4 (1.6–3.5)
•	Former smokers, not current cigar/pipe: 
1.9 (1.2–2.9)
•	Cigar/pipe smokers: 3.1 (2.0–4.8)
•	Cigarettes/day:
 – <10: 2.2 (1.2–3.8)
 – 10–20: 2.0 (1.3–3.0)
 – 21–39: 2.9 (1.8–4.5)
 – >39: 3.8 (1.9–8.0)
•	Duration (years):
 – <35: 0.9 (0.4–2.1)
 – 35–39: 2.6 (1.4–4.9)
 – >39: 2.7 (1.5–4.9)
•	Age started smoking (years):
 – <20: 2.9 (1.6–5.3)
 – 20–24: 2.3 (1.2–4.3)
 – >24: 1.0 (0.4–2.3)
Adjusted for age and calendar 
period; risks increased with the 
number of cigarettes/day, duration 
of smoking >35 years, and earlier 
age at initiation; did not control 
for consumption of alcohol or 
HBV status 
Shibata et al. 
1990 (Cohort I)




•	Current smoker: 1.1 (0.2–4.7)
•	Cigarettes/day:
 – 1–9: 0.6 (0.1–3.7)
 – ≥10: 1.2 (0.2–5.7)
 – p trend = ~0.6
Adjusted for age; calculations 
based on small number of liver 
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Shibata et al. 
1990 (Cohort II)




•	Former smoker: 2.9 (0.3–29.0)
•	Current smoker: 3.6 (0.6–22.3)
•	Cigarettes/day:
 – 1–9: 11.9 (1.5–96.8)
 – 10–19: 1.1 (0.1–10.6)
 – 20–29: 2.7 (0.4–19.2)
 – ≥30: 3.2 (0.4–23.7)
 – p trend = ~0.5
•	Consumers of alcohol, number of 
cigarettes/day:
 – 1–19: 2.1 (0.4–10.0)
 – ≥20: 1.9 (0.4–9.4)
Adjusted for age and consumption 
of alcohol






•	Former smoker: 0.9 (0.4–2.0)
•	Current smoker: 1.0 (0.5–1.8)
•	Pack-years:
 – <30: 0.8 (0.4–1.7)
 – ≥30: 0.9 (0.5–1.9)
 – p trend = 0.824
Adjusted for age and gender 






•	Ever smoker: 1.8 (0.6–5.6)
•	Cigarettes/day:
 – 1–19: 3.1 (1.0–10.3)
 – ≥20: 2.1 (0.6–6.9)
•	Duration (years):
 – 1–29: 2.6 (0.7–9.4)
 – ≥30: 2.5 (0.9–7.6)
Population-based controls 
matched on age, sample collection 
date, and residence; analysis of 
ever smokers adjusted for age, 
education level, residence, HBsAg 
positivity, exposure to aflatoxin, 
and heavy consumption of alcohol
Tsukuma et al. 
1993 
•	Participants were patients 





•	Current smoker: 2.3 (0.9–5.9)
•	Former smoker: 1.7 (0.6–4.5)
Adjusted for age, gender, disease 
stage, alpha-fetoprotein level, and 
consumption of alcohol 
Yu and Chen 
1993
•	Nested case-control study 
•	9,691 followed (all men)
•	35 cases
•	1987–1990
•	China, Province of Taiwan
•	Ever smoker: 1.2 (0.4–3.1) Controls matched by age, date 
of interview, and residence; 
adjusted for testosterone level, 
consumption of alcohol, HCV/
HBsAg status, consumption of 
vegetables, and history of liver 
disease
Chang et al. 
1994 




•	China, Province of Taiwan
•	Ever smoker: 1.2 (0.6–2.7) Controls matched for age, 
residence, and date of recruitment 
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•	Annual mortality rate for liver cancer 
(per 100,000 men):
 – Never smokers: 7
 – Former smokers: 9
 – Current smokers: 11
•	Annual mortality rate for liver cancer 
(per 100,000 men), cigarettes/day:
 – 1–14: 17
 – 15–24: 3
 – ≥25: 15
 – p trend = 0.7
No significant trend for the 
number of cigarettes/day






•	Hiroshima and Nagasaki, 
Japan
•	Ever smoker: 2.2 (1.5–3.2)
•	Current smoker: 2.2 (1.5–3.2)
•	Former smoker: 2.3 (1.5–3.6)
Adjusted for age, gender, and 
estimated radiation dose; 
no interaction with alcohol 
consumption and no dose-
response relationship with 
smoking intensity or duration 
London et al. 
1995
•	Nested case-control study




•	Current smoker: 0.7 (0.5–1.0) Controls matched 5:1 by age, 
area of residence, and HBV 
status; strong inverse association 




•	United States veterans, 
99.5% male





•	Former smoker: 1.5 (1.2–2.0)
•	Current smoker: 1.8 (1.4–2.3)
•	Ever smoker: 1.7 (1.3–2.2)
•	Cigarettes/day:
 – 1–9: 1.8 (1.1–2.8)
 – 10–20: 1.4 (1.1–2.0)
 – 31−39: 2.3 (1.6–3.1)
 – ≥40: 2.6 (1.4–4.6)
 – p trend = <0.01
Mortality study did not control 
for consumption of alcohol or 
viral status; adjusted for age and 
calendar year; increased risk with 
increased smoking intensity 




•	Ever smoker: 3.6 (1.3–10.6) Age-gender-adjusted analysis was 
significant, but smoking was not 
included in the final model, which 
adjusted for HBV, HCV, aflatoxin 
exposure, and family history of 
HCC
Chiba et al. 
1996 





•	<20 pack-years: 1.7 (0.8–3.7)
•	≥20 pack-years: 2.5 (1.1–5.5)
Adjusted for age, gender, 
consumption of alcohol, clinical 
stage of liver disease, serum 
alpha-fetoprotein value, HBV, 
history of blood transfusion, 
surgical procedures, and family 
history of liver cancer
Murata et al. 
1996 





 – 1–10: 1.4
 – 11–20: 2.0, p <0.05
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•	Ever smoker: 1.8, p <0.05
•	Cigarettes/day:
 – <20: 1.8
 – ≥20: 1.8
Adjusted for age and consumption 
of alcohol





•	Current smoker: 2.0 (p <0.05)
•	Cigarettes/day:
 – 1–19: 2.1
 – ≥20: 2.1
 – p trend = 0.07
Adjusted for age, blood pressure, 
cholesterol, and consumption of 
alcohol at baseline
Lam et al. 1997 •	Chinese factory workers 





•	Ever smoker, men: 1.1 (0.4–2.9) Adjusted for age, marital status, 
occupation, blood pressure, 
triglycerides, and total cholesterol 
Nordlund et al. 
1997





•	Current smoker: 0.7 (0.2–2.0) Adjusted for age and place of 
residence






•	Current smoker, men: 2.2 (1.4–3.6)
•	Cigarettes/day, men: 
 – ≤10: 2.1 (1.2–3.5)
 – 11–20: 1.9 (1.2–3.2)
 – >20: 1.8 (1.2–3.5)
 – p trend = 0.02
•	Duration (years), men:
 – ≤20: 1.6 (0.8–3.2)
 – 21–30: 1.0 (0.5–2.1)
 – >30: 2.5 (1.6–4.1)
•	Age (years) started smoking, men:
 – >24: 1.4 (0.8–2.6)
 – 21–24: 2.3 (1.2–4.2)
 – ≤20: 2.2 (1.4–3.7)
 – p trend = <0.01
•	Pack-years, men:
 – <20: 1.7 (1.0–2.9)
 – 20–40: 2.1 (1.2–3.5)
 – ≥41: 2.5 (1.3–4.6)
Adjusted for age, gender, alcohol 
intake, and HBsAg status; risk 
rose with increased pack-years, 
>30 years duration, and initiation 
at <25 years of age; inverse trend 
seen with number of cigarettes/
day; study partially overlapped 
with Wen et al. (2004) 








 – Men: 1.4 (1.3–1.5)
 – Women: 1.2 (1.1–1.3)
Estimates of risk ratio (standard 
error) after adjustment for age 
and study area (county or city)
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 – Urban: 1.5b
 – Suburban: 1.4
 – Rural: 1.5b
•	Ever smoker, women (urban): 2.4
p trend = <0.05 for smoking 
intensity for men and women and 
for age at initiation among men 
only
Sun et al. 1999 •	Subjects were all HBsAg 
positive




•	 Incidence rate/100 person-years:
 – Never smoker: 2.3
 – Current smoker: 1.6
 – p = 0.5
Mizoue et al. 
2000




•	Former smoker: 2.9 (1.0–8.4)
•	Current smoker: 3.3 (1.2–9.5)
•	Cigarettes/day:
 – 1–24: 3.5 (1.2–10.2)
 – ≥25: 2.8 (0.8–9.6)
Adjusted for age, area of residence, 
and consumption of alcohol; no 
dose-response effect with smoking 
intensity 




•	Ever smoker: 2.1 (0.6–7.2)
•	Pack-years: 
 – <10: 3.3 (0.4–28.2)
 – ≥10: 2.0 (0.6–6.9)
 – p trend = 0.3
Adjusted for age and gender
Evans et al. 
2002





•	Current smoker (age adjusted):
 – Men: 0.9 (0.8–1.1)
 – Women: 2.0 (0.9–4.2)
•	Female (multivariate), cigarettes/day:
 – 1–5: 1.5 (0.4–6.3)
 – 6–10: 2.0 (0.6–6.5)
 – ≥10: 4.2 (1.3–13.8)
Adjusted for HBV and 
consumption of alcohol among 
women; no interaction between 
HBsAg status and cigarette 
smoking; smoking was not 
significantly associated with liver 
cancer and was excluded from 
multivariate model in men; dose-
response association in women
Yang et al. 2002 •	Nested case-control study 




•	Ever smoker: 1.5 (1.0–2.2) Population-based controls 
matched on age, date of 
enrollment, and township; 
adjusted for age, consumption of 
alcohol, and HBV/HCV status





•	Ever smoker: 1.5 (1.1–2.3)
•	HBV negative: 2.5 (1.0–6.1)
•	HBV positive: 1.4 (0.9–2.2)
Adjusted for age, residence, and 
HBV and HCV infection





 – Male: 1.5 (1.3–1.7)
 – Female 1.1 (0.8–1.7)
•	Former smoker:
 – Male: 1.1 (1.0–1.3)
 – Female: 1.3 (0.8–2.1)
•	Ever smoker, male:
 – HBsAg positive: 29.0 (23.7–35.4)
 – HBsAg negative: 1.1 (0.9–1.4)
Adjusted for age, consumption 
of alcohol, diabetes, and HBsAg; 
no interaction between smoking, 
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•	Current smoker, men (age):
 – 40–59: 2.0 (0.8–5.1)
 – 60–69: 2.6 (1.2–5.8)
•	Current smoker, women (age):
 – 40–59: 2.8 (0.6–13.1)
 – 60–69: 1.5 (0.5–4.9)
•	Former smoker, men (age):
 – 40–59: 2.4 (0.8–6.8)
 – 60–69: 2.7 (1.2–6.1)
•	Former smoker, women (age)
 – 60–69: 1.2 (0.2–8.7)
No adjustments; 15–19 years 
of age at smoking initiation 
increased HR from 4 to 8 for 
current and former smokers 





 – Men: 1.5 (1.2–1.8)
 – Women: 5.0 (2.4–10.7)
Adjusted for age




•	Current smoker: 1.5 (1.3–1.7) Adjusted for age, residence, 
consumption of alcohol, physical 
activity, BMI, and diet; no trend 
with increasing duration of 
smoking 







 – HCV-positive: OR = 9.6 (1.5–61.4)
 – HCV-negative: OR = 1.7 (0.6–5.1)
•	Former smokers:
 – HCV-positive: OR = 7.8 (1.1–56.0)
 – HCV-negative: OR = 0.3 (0.0–1.7)
Adjusted for age, gender, diabetes, 
liver disease, and consumption of 
alcohol





 – Crude: 1.7 (1.2–2.3)
 – HBsAg positive: 1.0 (0.7–1.4)
 – HBsAg negative: 0.9 (0.6–1.4)
Participants were all HBsAg 
positive; adjusted for age, gender, 
consumption of alcohol, liver 
disease, and HBV virologic 
markers




•	Persons with chronic hepatitis C:
 – <20 pack-years: IRR = 1.8 (1.1–3.3)
 – ≥20 pack-years: IRR = 2.1 (1.2–3.6)
•	Persons with HCV-related cirrhosis:
 – <20 pack-years: IRR = 1.1 (0.7–1.9)
 – ≥20 pack-years: IRR = 1.1 (0.7–1.7)
Participants had HCV-related 
chronic hepatitis or cirrhosis; 
adjusted for consumption of 
alcohol, age, gender, and HBV/
HCV therapy 
Ohishi et al. 
2008
•	Nested case-control study 





•	Current smoker: 2.0 (0.8–5.0)
•	Former smoker: 1.1 (0.3–5.2)
Matched on age, gender, and 
city; adjusted for consumption of 
alcohol and coffee, BMI, diabetes, 
HBV/HCV markers, and estimated 
radiation dose 
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•	HBV/HCV negative (comparisons with 
never smokers):
 – Current smoker: 2.4 (1.2–5.0)
 – Former smoker: 1.0 (0.2–4.6)
•	HBV positive (comparisons with never 
smokers):
 – Current smoker: 1.1 (0.8–1.5)
 – Former smoker: 1.0 (0.5–2.0)
•	HCV positive (comparisons with never 
smokers):
 – Current smoker: 1.4 (0.6–3.3)
 – Former smoker: 2.9 (0.9–9.1)
Adjusted for age and gender
Di Costanzo et 
al. 2008 







•	Smoker: HR = 1.4 (0.80–2.3) Adjusted for age, gender, diabetes, 
consumption of alcohol, and 
interferon therapy
Lok et al 2009 •	HCV-infected patients 
with significant fibrosis or 





•	Ever smoker: HR = 2.1 (p = 0.07) Adjusted for age, race, alkaline 
phosphatase, des-carboxy 
prothrombin level, cirrhosis, 
esophageal varices, randomization 
group, and aspartate 
aminotransferase/platelet ratio 
index





 – Current smoker: HR = 1.6 (1.3–2.1)
 – Former smoker: HR = 1.1 (0.8–1.5)
•	Cigarettes/day among current smokers:
 – 1–12: HR = 1.53 (1.10–2.12)
 – >12 (86 cases): HR = 1.72 (1.28–2.30)
•	Years of smoking:
 – <20: HR = 1.1 (0.7–1.8)
 – ≥20: HR = 1.5 (1.2–1.9)
•	Pack-years of smoking:
 – <20: HR = 1.2 (0.9–1.7)
 – 20–39: HR = 1.5 (1.2–2.0)
 – ≥40: HR = 1.5 (1.1–2.2)
•	Results were similar when daily drinkers 
were excluded from the analysis.
•	P values for trend were significant 
for number of cigarettes/day, years of 
smoking, and pack-years of smoking
•	Among HBV- and HCV- participants, 
ever smoking was associated with a 
nonsignificant increased risk for HCC in 
all strata of alcohol consumption
Adjusted for age, gender, year 
of recruitment, dialect group, 
education level, BMI, diabetes, 
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 – Current smoker: 4.6 (1.9–10.9)
 – Former smoker: 2.0 (0.90–4.4) 
•	Men: 
 – Current smoker: 5.4 (1.7–16.8)
 – Former smoker: 1.7 (0.6–4.9) 
•	  Women:
 – Current smoker: 1.7 (0.3–8.5)
 – Former smoker: 1.4 (0.3–6.0) 
Matched by study site, age, gender, 
and calendar time of recruitment; 
women matched on menopausal 
status; adjusted for HBV/HCV 
status, education level, ethanol 
and coffee intake, and BMI







•	Current smoker: HR = 2.8 (0.6–13) Adjusted for age, gender, BMI, 
consumption of alcohol, levels of 
liver enzymes, and HBV molecular 
characteristics
Oh et al. 2012 •	6,694 followed
•	50 cases
•	1993–2003
•	Republic of Korea 
•	Current smoker: HR = 1.3 (0.6–2.6)
•	Former smoker: HR = 1.2 (0.4–3.3)
Models with smoking estimates 
did not include data pertaining 
to HBV and HCV; adjusted for age 
and gender only 
Sahasrabuddhe 
et al. 2012 
•	300,504 adults, 50–71 




•	Former smokers, by cigarettes/day: 
 – ≤20: HR = 1.2 (0.9–1.7)
 – >20: HR = 1.3 (0.9–1.9)
•	Current smokers, by cigarettes/day:
 – ≤20: HR = 2.4 (1.5–3.8)
 – >20: HR = 1.8 (1.0–3.4)
Unadjusted models
Notes: BMI = body mass index; CI = confidence interval; HBsAg = hepatitis B surface antigen; HBV = hepatitis B virus; HCV = 
hepatitis C virus; HR = hazard ratio; IRR = incident rate ratio; OR = odds ratio; pack-years = the number of years of smoking 
multiplied by the number of packs of cigarettes smoked per day; person-years = the sum of the number of years that each member of 
a population has been smoking.
aFindings are reported as relative risks and compared with never smokers, unless indicated otherwise.
bCI does not include 1.0.
Table 6.4S Continued
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Table 6.5S Prospective studies of cigarette smoking and colorectal cancer incidence, published 2002–2009 
Study Design/population Findings (95% CI) Adjustment(s) Comments 
Terry et al. 
2002b
•	89,835 women 
•	40–59 years of age at 
entry in 1980
•	363 colon cases; 164 
rectal cases 
•	Canada 
•	10.6 years follow-up 
•	Colorectal:
 – Current smokers: rate ratio = 1.0 (0.80–
1.26)
 – Former smokers: rate ratio = 1.15 (0.94–
1.41)
•	Rectal cancer:
 – 30–39 years since smoking initiation: rate 
ratio = 1.52 (95% CI, 1.01–1.26)a 
 – ≥40 years since smoking initiation: rate 









•	36,000 men and women 
enrolled 
•	1987–1991
•	20–59 years of age
•	Case cohort: 102 cases; 
537 controls
•	8.5 years follow-up
•	Duration of smoking (current smokers):
 – 1–15 years: OR = 1.0
 – 16–30 years: OR = 0.4 (0.1–1.9)
 – >30 years: OR = 1.9 (0.5–8.2)
 – p = 0.28
•	Duration of smoking (former smokers):
 – 1–15 years: OR = 1.0
 – 16–30 years: OR = 2.7 (1.03–7.4)
 – >30 years: OR = 3.2 (1.04–9.8)
 – p = 0.04








•	55–69 years of age at 
baseline in 1986




•	Current smokers: RR = 1.10 (0.89–1.37)
•	Former smokers: RR = 1.21 (1.01–1.45)
•	Duration of smoking:
 – 1–19 years: RR = 1.16 (0.89–1.52)
 – 20–39 years: RR = 1.08 (0.88–1.32)
 – ≥40 years: RR = 1.30 (1.04–1.63)
•	 Increasing duration of smoking significantly 







Otani et al. 
2003
•	90,004 men and women 
•	40–69 years of age in 1990 
•	298 colorectal cases 
(invasive only)
•	299 colon cases (invasive 
and noninvasive); 148 




 – Colorectal: RR = 1.6 (1.1–2.1)
 – Colon: RR = 1.4 (0.99–1.9)










•	≥35 years of age
•	1992 baseline data
•	104 colon cases in men; 
57 rectal cases in men
•	77 colon cases in women; 
38 rectal cases in women
•	 Japan
•	8 years follow-up 
•	Men (colon):
 – ≤20 pack-years: RR = 1.36 (0.79–2.33)
 – >20 pack-years: RR = 1.37 (0.81–2.32)
•	Men (rectal): 
 – ≤20 pack-years: RR = 1.33 (0.57–3.12)
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Study Design/population Findings (95% CI) Adjustment(s) Comments 










 – Colon: RR = 1.36 (0.97–1.92)
 – Rectal: RR = 1.31 (0.76–2.25)
Age, BMI NA
Wakai et al. 
2003
•	 JACC
•	25,260 men and 34,619 
women
•	40–79 years of age
•	Recruited 1988–1990





 – Current smokers: HR = 1.23 (0.85–1.78)
 – Former smokers: HR = 1.07 (0.72–1.59)
•	Men (rectal):
 – Current smokers: HR = 0.83 (0.55–1.26)
 – Former smokers: HR = 0.88 (0.56–1.39)
•	Women (colon):
 – Current smokers: HR = 1.06 (0.55–2.02)
 – Former smokers: HR = 1.07 (0.39–2.92)
•	Women (rectal):
 – Current smokers: HR = 0.36 (0.05–2.65)
 – Former smokers: HR = 1.05 (0.14–7.69)
•	Number of years of smoking not related to 
risk (p = 0.52)










•	Oxford Vegetarian Study 
•	11,140 participants 
•	16–89 years of age
•	1980–1984 
•	Colorectal cases: 16 
(current smokers), 




•	Current smokers: RR = 1.88 (1.03–3.44)




•	Netherlands Cohort Study 
on Diet and Cancer
•	58,279 men and 62,573 
women
•	50–69 years of age at 
entry in 1986
•	661 colorectal cases 
(excluding the first 2.3 
years of follow-up)
•	The Netherlands
•	7.3 years follow-up 
•	Current smokers: IRR = 0.91 (0.71–1.18)
•	Former smokers: IRR = 1.30 (1.03–1.65)
•	No significant trend for age at smoking 
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Study Design/population Findings (95% CI) Adjustment(s) Comments 
Yun et al. 
2005
•	Korean National Health 
Insurance Corporation
•	733,134 men
•	≥30 years of age in 1996 
•	Current smokers: 42.4 
years of age (mean)
•	Former smokers: 44.7 
years of age (mean)
•	417 colon cases; 453 
rectal cases 
•	Republic of Korea 
•	Followed through 2000
•	Colon: 
 – Current smokers: RR = 0.81 (0.63–1.05)
 – Former smokers: RR = 1.37 (1.06–1.77)
•	Rectal: 
 – Current smokers: RR = 0.97 (0.76–1.24)












•	Ever smokers: IRR = 1.23 (0.91–1.66) Age, gender NA
Kim et al. 
2006
•	14,103 men and women
•	100 colorectal cases 
•	Republic of Korea
•	Duration of smoking:
 – ≤45 years: RR = 1.51 (0.97–2.34)
 – >45 years: RR = 2.35 (1.16–4.74)
 – p ≤0.01





Akhter et al. 
2007
•	25,279 men 




•	Current smokers: RR = 1.47 (0.93–2.34)
























•	Colorectal (ever smokers): OR = 1.42 
(1.17–1.72) 
•	Colon:
 – Current smokers (1 pack/day): OR = 1.06 
(0.57–1.98)
 – Current smokers (2 packs/day): OR = 1.53 
(1.02–2.29)
 – Former smokers: OR = 1.50 (1.19–1.89)
•	Rectal:
 – Current smokers (1 pack/day): OR = 0.85 
(0.26–2.77)
 – Current smokers (2 packs/day): OR = 1.92 
(1.01–3.66)
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Study Design/population Findings (95% CI) Adjustment(s) Comments 




•	50–79 years of age in 1994
•	1,242 colorectal cases: 




 – Current smokers: HR = 1.03 (0.77–1.38)
 – Former smokers: HR = 1.12 (0.97–1.29)
•	Rectal:
 – Current smokers: HR = 1.95 (1.10–3.47)
 – Former smokers: HR = 1.15 (0.80–1.67)
•	Duration of smoking:
 – Colon
 o <20 years: HR = 0.95 (0.79–1.15)
 o 20–29 years: HR = 1.27 (1.02–1.58)
 o 30–39 years: HR = 1.18 (0.93–1.50)
 o ≥40 years: HR = 1.19 (0.93–1.54)
 – Rectum
 o <20 years: HR = 0.87 (0.52–1.43)
 o 20–29 years: HR = 1.95 (1.20–3.17)
 o 30–39 years: HR = 1.24 (0.68–2.27)
 o ≥40 years: HR = 1.53 (0.83–2.83)
•	Current smokers had a significantly 








Tsong et al. 
2007
•	61,321 men and women
•	45–74 years of age
•	Recruited 1993–1998
•	845 colorectal cases: 516 




 – Current smokers: HR = 0.83 (0.64–1.06)
 – Former smokers: HR = 0.96 (0.73–1.27)
•	Rectal:
 – Current smokers: HR = 1.63 (1.23–2.17)








Age at smoking 
initiation related 
to rectal cancer 
but not colon 
cancer; duration 
of smoking 
related to rectal 
cancer but not 
colon cancer 
Hooker et al. 
2008
•	91,908 households in 
1963 census: 20,926 men; 
24,823 women
•	90,225 households in 






 – Current smokers: RR = 3.05 (1.19–7.82)
 – Former smokers: RR = 2.63 (0.98–7.05)
•	Men (1975 cohort):
 – Current smokers: RR = 1.80 (0.88–3.67)
 – Former smokers: RR = 1.92 (0.98–3.78)
•	Women (1963 cohort):
 – Current smokers: RR = 0.93 (0.48–1.80)
 – Former smokers: RR = 0.62 (0.19–2.08)
•	Women (1975 cohort):
 – Current smokers: RR = 1.57 (0.89–3.76)





Gram et al. 
2009
•	68,160 women
•	30–69 years of age at 
enrollment in 1996–1998 
•	425 colorectal cases: 284 




 – Colorectal: rate ratio = 1.2 (1.0–1.5)
 – Colon: rate ratio = 1.3 (1.0–1.7)
 – Rectal: rate ratio = 1.1 (0.7–1.5)
•	Years smoked significant for colorectal 
cancer (p = 0.04)
•	No significant trends for individual sites
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Study Design/population Findings (95% CI) Adjustment(s) Comments 
Hannan et 
al. 2009
•	Cancer Prevention Study 
II 
•	184,187 men and women
•	50–74 years of age




•	Among current smokers, relative risk 
greatest for current smokers of long 
duration (p = 0.052)









Notes: BMI = body mass index; CI = confidence interval; CLUE II = Campaign Against Cancer and Heart Disease; DCMP = Dutch 
Cardiovascular Monitoring Project; HR = hazard ratio; IRR = incidence rate ratio; JACC = Japanese Collaborative Cohort Study for 
Evaluation of Cancer Risk; NA = not applicable; OR = odds ratio; pack-years = the number of years of smoking multiplied by the 
number of packs of cigarettes smoked per day; RR = relative risk.
aThe RR does not fall within the CI. The information presented here appears just as it does on page 481 of Terry and colleagues (2002).
Table 6.5S Continued
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Table 6.6S Case-control studies of cigarette smoking and colorectal cancer incidence, published 2001–2008
Study Design/population Findings (95% CI) Adjustment(s) Comments 







 – Ever smokers: 1.3 (1.0–1.8)
 – Former smokers: 1.5 (1.1–2.0)
 – Current smokers: 1.0 (0.7–1.5)
•	Men (rectal):
 – Ever smokers: 1.3 (1.0–1.8)
 – Former smokers: 1.4 (1.0–1.8)
 – Current smokers: 1.3 (0.9–1.9)
•	Women (colon):
 – Ever smokers: 1.3 (0.9–1.7)
 – Former smokers: 1.6 (1.1–2.2)
 – Current smokers: 1.0 (0.7–1.4)
•	Women (rectal):
 – Ever smokers: 1.0 (0.7–1.3)
 – Former smokers: 1.2 (0.8–1.8)
 – Current smokers: 0.7 (0.5–1.1)
Age, total energy 
in dietary intake, 
other
NA





 – Current smokers: 0.8 (0.6–1.0)
 – Former smokers: 0.9 (0.6–1.3)
•	Men (rectal):
 – Current smokers: 0.9 (0.7–1.2)
 – Former smokers: 1.1 (0.7–1.6)
•	Women (colon):
 – Current smokers: 0.6 (0.4–1.0)
 – Former smokers: 0.6 (0.3–1.5)
•	Women (rectal):
 – Current smokers: 0.9 (0.5–1.3)
 – Former smokers: 1.4 (0.7–3.0)
•	No significant trend for RRs according to 
duration of smoking or pack-years among men 
and women
Age, alcohol, other NA
Diergaarde 




•	Ever smokers: 1.00 (0.60–1.50) Age, gender, 
alcohol
NA















 – Colon: 0.97 (0.71–1.33)





Ho et al. 
2004 





 – Colon: 0.84 (0.58–1.21)
 – Rectal: 1.44 (1.00–2.06)
•	No significant trend with duration of smoking 
and cigarettes smoked/day












•	No statistically significant differences between 
cases and controls
NR No data 
presented
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Study Design/population Findings (95% CI) Adjustment(s) Comments 





•	Ever smokers: 1.43 (0.94–2.18) Age, gender After reporting, 
main effect 
analysis 
focuses on GST 
genotypes and 
risk














•	Ever smokers: 1.4 (1.2–1.6)
•	Current smokers: 1.7 (1.4–2.1)
•	Former smokers: 1.2 (1.1–1.4)
•	Duration of smoking (>40 years): 1.6 (1.2–2.1)
•	Significant trend with duration of smoking 
(p = 0.007)















Gao et al. 
2007 





 – Colorectal: 1.01 (0.69–1.47)
 – Colon: 0.84 (0.49–1.44)










 – Proximal: 1.20 (0.90–1.50)
 – Distal: 1.00 (0.80–1.20)
•	Men (ever smokers):
 – Proximal: 1.20 (0.90–1.60)
 – Distal: 1.10 (0.90–1.40)









 – Current smokers: 1.32 (0.99–1.76)
 – Former smokers: 1.21 (0.97–1.50)
•	Women:
 – Current smokers: 1.17 (0.85–1.62)
 – Former smokers: 1.32 (1.02–1.71)
•	Trend with duration of smoking and intensity 
not significant










•	Current smoker: RR = 1.42 (1.02–1.99)
•	Former smoker: RR = 1.62 (1.28–10.08)
Age, alcohol, other NA





•	Current smokers: 0.86 (0.65–1.14)
•	Former smokers:
 – <10 years: 1.05 (0.78–1.43)
 – >10 years: 1.18 (0.90–1.53)
Age, gender, BMI, 
diet
Not related to 
rectal cancer
Note: Findings are presented as odds ratios unless indicated otherwise. BMI = body mass index; CI = confidence interval; NA = not 
applicable; NR = not reported; pack-years = the number of years of smoking multiplied by the number of packs of cigarettes smoked 
per day; RR = relative risk.
Table 6.6S Continued
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Table 6.7S Prospective studies of cigarette smoking and colorectal cancer mortality, published 2002–2009




•	55–69 years of age at 
baseline in 1986 
•	249 cdolorectal deaths 
•	United States 
•	Followed through 1999
•	Current smokers: RR = 1.58 (1.09–2.29)
•	Former smokers: RR = 1.14 (0.80–1.62)
•	Duration of smoking:
 – 1–19 years: RR = 1.53 (0.96–2.43)
 – 20–39 years: RR = 1.02 (0.67–1.53)
 – ≥40 years: RR = 1.55 (1.04–2.31)
•	 Increasing duration of smoking-related 







years (p trend = 
0.05)
Colangelo 
et al. 2004 
•	Chicago Heart Association 
Detection Project in 
Industry Study
•	39,299 men and women
•	Recruited 1967–1973
•	208 colorectal deaths 
(men): 141 women 
•	26 years follow-up








analysis, but not in 
multivariate analysis
Jee et al. 
2004 
•	1,212,906 men and women
•	30–95 years of age
•	Up to 511 cases
•	Republic of Korea
•	9 years follow-up
•	Current smokers: RR = 1.1 (0.8–1.4)
•	Former smokers: RR = 1.1 (0.9–1.4)
NR Most current 
smokers consumed 
less than 1 pack of 
cigarettes/day
Wen et al. 
2004 
•	53,091 participants 
(combines two cohorts: 
1982–1992 and 1989–1992) 




 – Colon: RR = 0.84 (0.54–1.30)
 – Rectal: RR = 2.06 (1.01–4.18)
NR NA
Doll et al. 
2005 
•	34,439 participants 
recruited in 1951 
•	549 colon deaths; 201 rectal 
deaths
•	Europe
•	Significant trend for cigarettes smoked and 
risk of rectal cancer 
•	Relatively weak relationship between 
smoking and colorectal cancer
•	 Implausibly strong relationship between 
smoking and rectal cancer








•	6.8 years follow-up 
(average)





•	 JACC Study 
•	607 cases 
•	Men: 200 colon deaths; 152 
rectal deaths




 – Colon: HR = 1.18 (0.80–1.72)
 – Rectal: 1 HR = 0.31 (0.85–2.01)
•	Current smokers (women):
 – Colon: HR = 0.67 (0.29–1.53)
 – Rectal: HR = 1.31 (0.52–3.29)
NR NA
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•	40–69 years of age at 
baseline 




 – Current smokers: HR = 1.33 (0.96–1.86)
 – Former smokers: HR = 1.11 (0.80–1.55)
•	Rectal:
 – Current smokers: HR = 1.51 (0.84–2.74)
 – Former smokers: HR = 1.94 (1.11–3.39)
NR NA
Kenfield 
et al. 2008 
•	Nurses’ Health Study
•	104,519 women
•	34–59 years of age at 
baseline in 1980, when 




•	Current smokers: HR = 1.63 (1.29–2.05)











but not significant 
in multivariate 
analysis
Note: BMI = body mass index; CI = confidence interval; HR = hazard ratio; JACC = Japanese Collaborative Cohort Study for 
Evaluation of Cancer Risk; NA = not applicable; NR = not reported; RR = relative risk.
Table 6.7S Continued
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Table 6.9S  Epidemiologic cross-sectional studies on the association between cigarette smoking and stage and 
histologic grade at diagnosis of prostate cancer
Study Design/population Findings by measure of smoking: OR (95% CI)
Hussain et al. 
1992
•	Cases treated with external beam 
radiation and surgery at 1 hospital
•	670 cases 
•	Dates of diagnoses: 1980–1990
•	Disease stage among nonsmokers:a
 – Stage A: 4.4%
 – Stage B: 35.6%
 – Stage C: 6.7%
 – Stage D: 53.3%
•	Disease stage among smokers:a
 – Stage A: 4.4%
 – Stage B: 17.4%
 – Stage C: 9.9%
 – Stage D: 68.3%
•	Histologic grade among nonsmokers:b
 – Well differentiated: 37.1%
 – Moderately differentiated : 45.2%
 – Poorly differentiated: 17.7%
•	Histologic grade among smokers:b
 – Well differentiated: 15.0%
 – Moderately differentiated: 27.1%
 – Poorly differentiated: 57.9%
Daniell 1995 •	Cases seen at 1 community hospital
•	359 cases 
•	Dates of diagnoses: 1983–1990
•	Disease Stage D vs. nonstage A, by smoking status:
 – Nonsmoker: 1.0 (referent)
 – Smoker: 2.1 (1.3–4.3)c
Kobrinsky et 
al. 2003
•	Cases recorded in a regional cancer 
registry 
•	2,311 cases 
•	Dates of diagnoses: 1986–2001
•	Metastatic (SEER cancer stage 7) by smoking status:
 – Never smoker: 1.00 (referent)
 – Former smoker: 0.94 (0.72–1.21)
 – Current smoker: 1.53 (1.17–2.02)
•	Regional (SEER cancer stages 3, 4, 5) by smoking status:
 – Never smoker: 1.00 (referent)
 – Former smoker: 1.01 (0.63–1.63)
 – Current smoker: 1.83 (1.09–3.06)
Surgeon General’s Report
S-46     Chapter 6 Tables Supplement
Study Design/population Findings by measure of smoking: OR (95% CI)
Roberts et al. 
2003
•	Clinically localized cases treated with 
surgery by 1 surgeon
•	Diagnosed between 1992–1999
•	352 cases
•	Gleason score ≥7 vs. <7, by smoking status:
 – Never smoker: 1.00 (referent)
 – Former smoker: 0.72 (0.44–1.19)
 – Current smoker: 1.76 (0.66–4.72)
•	Extraprostatic disease vs. not, by smoking status:
 – Never smoker: 1.00 (referent)
 – Former smoker: 1.49 (0.92–2.42)
 – Current smoker: 3.85 (1.44–10.33)
•	Gleason score ≥7 or extraprostatic vs. not, by smoking status:
 – Never smoker: 1.00 (referent)
 – Former smoker: 1.47 (0.84–2.56)
 – Current smoker: 3.17 (1.13–8.85)
•	Gleason score ≥7 vs. <7, by pack-years of smoking:
 – Never smoker: 1.00 (referent)
 – ≤10: 0.57 (0.31–1.06)
 – >10–20: 1.03 (0.45–2.38)
 – >20–30: 0.68 (0.26–1.76)
 – >30–40: 1.76 (0.52–5.97)
 – >40: 2.01 (0.65–6.24)
 – p trend = 0.16
•	Extraprostatic disease vs. not, by pack-years of smoking:
 – Never smoker: 1.00 (referent)
 – ≤10: 1.23 (0.69–2.18)
 – >10–20: 2.29 (1.03–5.10)
 – >20–30: 1.45 (0.60–3.51)
 – >30–40: 3.01 (0.90–10.03)
 – >40: 3.66 (1.18–22.29)
 – p trend = 0.005
•	Gleason score ≥7 or extraprostatic vs. not, by pack-years of 
smoking:
 – Never smoker: 1.00 (referent)
 – ≤10: 1.05 (0.53–2.07)
 – >10–20: 2.03 (0.84–4.91)
 – >20–30: 1.82 (0.71–4.66)
 – >30–40: 3.84 (1.07–13.73)
 – >40: 3.37 (1.04–10.98)
 – p trend = 0.003
Table 6.9S Continued
Cancer     S-47
The Health Consequences of Smoking —50 Years of Progress
Study Design/population Findings by measure of smoking: OR (95% CI)
Moreira et al. 
2010
•	Localized cases treated with surgery
•	1,267 cases
•	Dates of diagnoses: 1998–2008
•	Gleason score among current smokers at prostatectomy:d 
 – 2–6 : 35%
 – 3+4: 44% 
 – ≥4+3: 21%
•	Gleason score among nonsmokers at prostatectomy:d 
 – 2–6: 41%
 – 3+4: 39%
 – ≥4+3: 20%
•	Extraprostatic extension by smoking status at prostatectomy:
 – Smoker: 25%
 – Nonsmoker: 18%
 – p = 0.003
•	 Invasion of seminal vesicles by smoking status at prostatectomy:
 – Smoker: 10%
 – Nonsmoker: 6%
 – p = 0.03
•	Lymph-node positive by smoking status at prostatectomy:
 – Smoker: 2% 
 – Nonsmoker: 2%
 – p = 0.52 (out of those with known lymph node status)
Note: CI = confidence interval; OR = odds ratio; pack-years = the number of years of smoking multiplied by the number of packs of 
cigarettes smoked per day; SEER = Surveillance, Epidemiology, and End Results Program. Gleason sum is the sum of the 2 scores 
given by the pathologist on examination of the prostatic tissue.
aDistribution of stage by smoking status; p = 0.01.
bDistribution of grade by smoking status; p <0.00005.
cResults adjusted for multiple variables, including grade.
dDistribution by smoking status: p = 0.15.
Table 6.9S Continued
Surgeon General’s Report
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Cancer     S-125
The Health Consequences of Smoking —50 Years of Progress
Table 6.20S Reports on the association between active cigarette smoking and risk of a second primary contralateral 
breast cancer (n = 7)
Study Design/population Cases/noncases Measure of smoking: RR (95% CI)




•	49 years of age
•	 Japan






•	20–93 years of age
•	8 hospitals
•	Connecticut
292/264 Ever: 0.8 (0.5–1.3)
≥40 years duration: 1.5 (0.7–3.2)
≥1 pack/day: 1.7 (0.9–3.1)




•	Cancer and Steroid Hormone Study 
(8 SEER sites)
•	1980–1982
•	20–54 years of age
136/4,550 Ever: 1.24 (0.87–1.77)
<19 years of age at smoking initiation: 1.24 (0.80–1.92)




•	22–88 years of age
•	Pennsylvania
87/1,253 Ever: ~0.5 (p = 0.04) 
Trentham-




•	18–79 years of age
•	Wisconsin
488/10,953 Current: 1.00 (0.78–1.28)
Former: 1.09 (0.89–1.35)





•	<55 years of age
•	 Iowa, Los Angeles and Orange 
County in California, Seattle, 
Denmark
708/1,399 Ever: 1.1 (0.9–1.6)
Ever, risk period: 1.2 (0.9–1.5)
≥20 years duration: 1.1 (0.9–1.5)
>0.5 packs/day (mean): 1.1 (0.8–1.4)
19 pack-years: 1.1 (0.8–1.4)
<20 years of age at smoking initiation: 1.1 (0.9–1.4)
Li et al. 2009e •	Nested case control
•	1990–2005
•	40–79 years of age
•	Seattle-Puget Sound 
•	4 counties in Western Washington
365/726 Current, baseline:   1.8 (1.1–3.2)
Current, reference:   2.2 (1.2–4.0)
Note: CI = confidence interval; pack-years = the number of years of smoking multiplied by the number of packs of cigarettes smoked 
per day; RR = relative risk; SEER = Surveillance, Epidemiology, and End Results Program; WECARE = Women’s Environmental 
Cancer and Radiation Epidemiology Study.
aAscertained from women identified through a cancer clinic; no information on stage is provided. The referent group for measure of 
smoking is based on women who smoked <10 cigarettes/day.
bAscertained from women identified through either the state cancer registry (Horn and Thompson 1988; Trentham-Dietz et al. 2007a) 
or through the SEER Program (Bernstein et al. 1992) and diagnosed with a first primary breast cancer (controls) or a second primary 
breast cancer diagnosed in the contralateral breast (cases). 
cAscertained from women identified through clinics with Stage I–II breast cancer over a median follow-up time of 8.9 years. Rate ratio 
calculated for this table based on cumulative incidence for smokers = 5% and 10% for nonsmokers at 10-year follow-up. Missing data 
for smoking history for 38% of subjects.
dAscertained from women identified through population-based cancer registries with either a first primary invasive breast cancer with 
no regional lymph node involvement (controls) or a second primary in situ or invasive breast cancer diagnosed in the contralateral 
breast no more than 1 year after the first breast cancer diagnosis (cases). The referent group was never smokers for all categories with 
the exception of ‘Ever, risk period’, which was defined as starting prior to or during the period between the first diagnosis and the 
reference date and stopping during or after this period.
eAscertained from women identified through a population-based cancer registry with Stage I–IIIB and ER+ breast cancer; baseline 
= first breast cancer diagnosis; reference = date of contralateral breast cancer diagnosis for cases and for controls the date of the 
matched patient’s contralateral diagnosis.
Surgeon General’s Report
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S-250     Chapter 7 Tables Supplement





Findings (95% CI 
or p value) Comments
Scott et al. 
1990 
•	Patients seen by respiratory 






 – OR = 0.93 (0.37–2.35)
Iwai et al. 
1994 
•	Patients identified by members 
of two research committees
•	86 cases
•	172 healthy controls 
•	86 hospital controls 
•	 Japan
NR •	Smoker
 – RR = 2.9 (p <0.01)
RR estimate limited 




•	Patients identified from 4 
teaching and 5 general hospitals
•	225 cases 




 – OR = 1.57 (1.01–2.43)
 – 10 pack-years of smoking
 – OR = 11.05 (0.99–1.12)
Community controls 
from same general 
practitioner as cases
Baumgartner 
et al. 1997 
•	Patients identified from 16 
institutions Untied States
•	248 cases  and 491 age-, gender-, 
and region-matched controls 
•	Studied during 1989–1993
•	Ever smoker
 – OR = 1.59 (1.1–2.4)
•	Pack-years
 – ≤20, OR = 1.00
 – 21–40, OR = 2.26 (1.3–3.8)
 – >40, OR = 1.12 (0.7–3.9)
Baumgartner 
et al. 2000 
•	Patients identified from 16 
institutions
•	248 cases
•	  491 age-, gender-, and region-









metal dust, talc, 
livestock
•	Ever smoker
 – OR = 1.59 (1.1–2.4)
•	Ever smoker (adjusted)
 – OR = 1.8 (1.2–2.7)
Enomoto et 
al. 2003 
•	Patients admitted to Nippon 
Medical School Hospital
•	52 cases
•	184 controls (randomly selected 
from clinic patients undergoing 
medical examination with no 











 – OR = 5.4 (2.30–12.66)
Diagnosis based 
on clinical history 
and examination, 
high-resolution 
CT scan along 






Respiratory Diseases     S-251





Findings (95% CI 
or p value) Comments
Miyake et al. 
2005 
•	Patients identified from 50 
hospitals
•	102 cases
•	59 controls (>40 years of age, 
without prior respiratory 
disease, treated at the same 
hospital for respiratory illness as 






 – OR = 2.21 (0.82–6.04)
•	Current smoker
 – OR = 0.5 (0.10–2.24)
•	Pack-years 
 – 0.6–19.9, OR = 0.87 (0.25–
3.10)
 – 20.0–39.9, OR = 3.23 (1.01–
10.84)
 – 40.0–59.9, OR = 2.22 (0.70–
7.23)
 – ≥60.0, OR = 1.59 (0.46–5.64)
Diagnosis based 
on clinical history, 
examination, high-
resolution CT scan, 
and, when available, 
lung biopsy, 
transbronchial 
lung biopsy, and 
bronchoalveolar 
lavage
Steele et al. 
2005 
•	Patients identified from Web-
based advertising and direct 
mailing to physician members 
of ATS
•	111 families having ≥2 members 
with idiopathic interstitial 
pneumonia 
•	309 cases 
•	360 controls (unaffected family 
members)
•	United States
Age, gender •	Ever smoker
 – OR = 3.6 (1.3–9.8)











 – Males, OR = 3.36a
 – Females, OR = 0.90a
Hubbard et 
al. 2008 
•	Longitudinal, electronic primary 
care database
•	920 cases 




 – OR = 1.11 (0.94–1.31)
Primary aim of study 
was to determine 
association 














 – OR=5.03 (1.12–22.68)
Cases of interstitial 
fibrosis diagnosed 
at autopsy, smoking 









Findings (95% CI 
or p value) Comments
Garcia-
Sancho et al. 
2011 
•	Newly diagnosed patients at 
National Institute of Respiratory 
Diseases 
•	100 cases
•	263 neighborhood controls 
•	Studied during 2007–2009
•	Mexico
Parent or sibling 
with IPF;











 – OR=2.5 (1.4-4.6)
Note: ATS = American Thoracic Society; CI = confidence interval; CT = computed tomography; NR = not reported; OR = odds ratio; 
pack-years = the number of years of smoking multiplied by the number of packs of cigarettes smoked per day; PFT = pulmonary 
function testing; RR = relative risk. 





Table 8.6S Detailed description of studies on smokefree laws and coronary events     S-255
Table 8.7S Detailed description of studies on smokefree laws and cerebrovascular accidents     S-281




Cardiovascular Diseases     S-255
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Table 9.3S Summary of studies of orofacial clefts and maternal smoking, 2002–2011     S-297
Table 9.4S Summary of studies of maternal smoking and clubfoot, 1999–2011     S-300
Table 9.5S Summary of studies of maternal smoking and gastroschisis, 1999–2011     S-302
Table 9.6S Summary of studies of maternal smoking and congenital heart defects, 1999–2011     S-304
Table 9.7S Summary of studies of maternal smoking and craniosynostosis, 1999–2011     S-307
Table 9.8S Summary of studies of maternal smoking and anorectal atresia, 1999–2011     S-308
Table 9.10S Studies on associations between prenatal smoking and disruptive behavioral in children, 2000–2012     
S-309
Table 9.11S Studies on associations between prenatal smoking and anxiety and depression in children, 2000–2012     
S-329
Table 9.12S Studies on the associations between prenatal smoking and Tourette syndrome in children, 2000–2011     
S-333
Table 9.13S Studies on associations between prenatal smoking and intellectual disability in children, 2000–2009     
S-334
Table 9.14S Association between maternal smoking and ectopic pregnancy, studies included in 2001–2010 Surgeon 
General’s reports and subsequently published through March 2013     S-335
Table 9.15S  Studies on the effect of maternal active smoking on spontaneous abortion (SAB) risk     S-340
Table 9.16S Experimental studies of the association between smoking and erectile dysfunction     S-342
Table 9.17S Cross-sectional studies of the association between smoking and the risk of erectile dysfunction     S-343

Reproductive Outcomes     S-297
The Health Consequences of Smoking —50 Years of Progress
Table 9.3S Summary of studies of orofacial clefts and maternal smoking, 2002–2011 
Study Design/population Definition of smoking Findings (95% CI)
Little et 
al. 2004a
•	 Infants with nonsyndromic orofacial 
clefts
•	112 CL/P and 78 CP cases 
•	248 unaffected controls 
•	Study period: September 1997–
January 2000
•	England (some regions) and Scotland 
Self-reported smoking in the 
first trimester, with frequency 
and duration of smoking also 
obtained, collected by interview 
after the end of the pregnancy; 
questions also on exposure to 
secondhand smoke at home, 
work, and other locations
•	First-trimester maternal smoking 
was associated with all orofacial clefts 
combined, OR = 2.0 (1.3–3.1), with 
CL/P, OR = 1.9 (1.1–3.1), and with CP, 
OR = 2.3 (1.3–4.1)
•	There was evidence of a dose-response 




•	Recruited mothers of children with 
and without orofacial clefts in 2003
•	57 with CL/P, 17 with CP, and 283 
controls
•	Philippines
Self-reported smoking during 
pregnancy
•	No association between maternal 
smoking and orofacial clefts (OR = 
0.84)
•	Relatively low prevalence of maternal 




•	Case-control triad study of 
nonsyndromic orofacial clefts
•	284 CL/P and 66 CP cases 




Self-reported smoking in 
the periconceptional period, 
defined as 3 months before 
pregnancy through the end of 
the first trimester; data collected 
approximately 24 months after 
periconceptional period
•	Reported maternal smoking (any 
amount) during the periconceptional 
period was not significantly associated 
with CL/P, OR = 1.2 (0.8–1.8), or with 
CP, OR = 0.9 (0.5–1.8)
•	Reported paternal smoking had 
borderline associations with CL/P, 





•	134 CL/P and 58 CP cases 




Self-reported smoking, with data 
collected during pregnancy, mean 
gestational age at data collection 
(week 17); any smoking during 
pregnancy; number of cigarettes/
day in first trimester
•	Combined effect estimate for all 
orofacial clefts excluding syndromes, 
OR = 1.52 (1.05–2.14) 
•	Any smoking during pregnancy was 
moderately associated with CL/P, 
OR = 1.48 (0.97–2.24) and with CP, 
OR = 1.53 (0.83–2.82)
•	Strongest effect estimates 
were observed for those reporting the 
heaviest smoking (>20 cigarettes/day), 






•	Excluded infants with syndromes and 
single-gene disorders
•	1,128 CL/P and 621 CP cases 
•	4,094 control infants without birth 
defects
•	 Infants born after October 1, 1997, 
with an estimated date of delivery on 
or before December 31, 2002
•	United States 
Self-reported periconceptional 
smoking, data collected after 
pregnancy completion; any 
reported smoking from the 
month before pregnancy through 
the end of the first trimester
•	Periconceptional smoking was 
associated with all orofacial clefts 
combined, OR = 1.37 (1.20–1.57)
•	Prior analyses in this dataset (Honein 
et al. 2007) showed  a stronger 
association for heavy smoking (>25 
cigarettes/day) and CL/P, OR = 1.8 
(1.0–3.2), in particular for heavy 






•	181 infants with orofacial clefts
•	Clinic-based case-control study in 
nine large cleft teams
•	Births from 1997–2000 
•	The Netherlands
Self-reported maternal 
periconceptional smoking (3 
months before to 3 months after 
conception)
•	Periconceptional smoking was 
associated with orofacial clefts, but the 
finding was nonsignificant, with OR = 
1.6 (0.9–2.7)
Surgeon General’s Report
S-298     Chapter 9 Tables Supplement
Table 9.3S Continued




•	Nonsyndromic orofacial clefts:  164 
infants with CL/P and 76 infants with 
CP





Self-reported regular smoking of 
at least one cigarette per day in 
the first trimester of pregnancy
•	First trimester smoking was not 
associated with orofacial clefts, OR = 
1.0 (0.7–1.6)
•	Among nonsmokers, exposure to 
tobacco smoke was associated with 
orofacial clefts, OR = 1.8 (1.2–2.8)
Grewal et 
al. 2008
•	502 infants with CL/P and 199 infants 
with CP
•	Births from selected counties (Los 
Angeles, San Francisco, and Santa 
Clara)
•	Births July 1999–June 2003
•	California
Self-reported smoking during 
the first month of pregnancy, 
data collected after pregnancy 
completion; smoking categorized 
as >5 or ≤5 cigarettes/day for the 
first month of pregnancy
•	 Infants with an isolated cleft were 
analyzed separately from those with 
multiple major unrelated defects
•	There were no significant associations 
observed for smoking in the first 






•	208 CL/P and 66 CP cases 0–24 
months of age
•	548 controls
•	Study period: 2005 
•	Rio de Janeiro, Brazil 
Maternal smoking in the year 
before pregnancy and maternal 
smoking in the first trimester
•	Maternal smoking in the year before 
pregnancy was associated with CL/P, 
OR = 1.59 (1.04–2.44), but not with CP
•	No significant associations for first-
trimester smoking with CL/P or CP
Shaw et 
al. 2009
•	89 infants with CL/P and 
409 unaffected infants
•	Mid-pregnancy serum specimens 
from the 15th to 18th week of 
pregnancy collected from 2003–2005 
•	Women in selected regions of 
California 
Mid-pregnancy serum cotinine 
levels of ≥2 ng/mL defined as 
exposed to maternal smoking; <2 
ng/mL defined as unexposed 




•	Orofacial clefts identified from 
a population based birth defects 
surveillance program
•	Births 2000–2007
•	Controls matched by gender, address, 
and date of birth
•	606 infants with orofacial clefts and 
no other major birth defects
•	Shenyang, China
Self-reported smoking from one 
month before to two months after 
last menstrual period
•	Prevalence of maternal smoking was 
very low (2.0% of case-mothers and 
1.4% of control-mothers)
•	Maternal smoking was higher among 
case-mothers, but association was not 
significant, OR = 1.50 (0.52–4.36)
•	Paternal smoking was associated with 
orofacial clefts, OR = 2.05 (1.47–2.87)
Lebby et 
al. 2010
•	Births (birth certificate records)
•	Study period: 2005
•	United States 
Smoking during pregnancy, 
reported on the birth certificate
•	Maternal smoking was associated with 
orofacial clefts, OR = 1.66 (1.32–2.09)




•	Shanxi province, China 
Exposure to passive smoking 
at least once a week from 1 
month before to 2 months after 
conception
•	Exposure to passive smoking was 
associated with CL/P, AOR = 2.0 
(1.2–3.4)
•	Stronger effect estimate for those 
exposed >6 times per week, OR = 2.8, 
than for those exposed 1–6 times per 
week, OR = 1.6
Reproductive Outcomes     S-299
The Health Consequences of Smoking —50 Years of Progress
Table 9.3S Continued








Self-reported smoking in the first 
trimester from a questionnaire 
completed by mothers
•	First trimester smoking was associated 









Smoking during pregnancy •	Smoking during pregnancy was more 
common among mothers of infants 
with clefts than controls, but it was 
very rare overall
Jia et al. 
2011 
•	Sichuan University, Department of 
Cleft Lip and Palate Surgery 





Self-reported maternal, paternal, 
and passive smoking
•	Maternal passive exposure to tobacco 
during early pregnancy was associated 
with nonsyndromic orofacial clefts 
combined, AOR = 1.42 (6.87–19.00)
•	 In unadjusted analyses, the association 
with passive smoking was reported for 
both CL/P and CP
Mirilas et 
al. 2011 
•	Aristotle University, Pediatric 
Surgery Department 
•	35 cases operated on for 
nonsyndromic CL/P




smoking and passive smoking 
before and during pregnancy 
(first 3 months)
•	Maternal passive exposure to tobacco 
was associated with increased risk of 
CL/P, OR = 1.81 (0.69-4.74), but the 
association was not significant
Zhang et 
al. 2011 
•	304 infants with nonsyndromic 
orofacial clefts (140 with CLP, 77 




Self-reported maternal smoking 
(6 months before pregnancy 
and in the first trimester), 
paternal smoking (1 month 
before pregnancy through first 
trimester), and passive smoking
•	AOR for maternal smoking before 
pregnancy was 4.97 (1.39–17.76) 
for CLO and 3.37 (1.04–10.88) for 
CLP for those reporting smoking 
1–9 cigarettes/day before pregnancy; 
estimates were similar for maternal 
smoking in the first trimester
•	No association with maternal smoking 
and CP
•	Paternal smoking in the 
periconceptional period was strongly 
associated with CLP, CLO, and CP
•	The medium level of exposure to 
environmental tobacco smoke at home 
or work was associated with orofacial 
clefts 
Notes: AOR = adjusted odds ratio; CI = confidence interval; CL/P = cleft lip with or without cleft palate; CLO = cleft lip only; 
CLP = cleft lip with cleft palate; CP = cleft palate; mL = milliliters; n = sample size; NBDPS = National Birth Defects Prevention 
Study; ng = nanogram; OR = odds ratio. 
Surgeon General’s Report
S-300     Chapter 9 Tables Supplement
Table 9.4S  Summary of studies of maternal smoking and clubfoot, 1999–2011
Study by defect Design/population Definition of smoking Findings (95% CI)
Honein et al. 
2000
•	346 infants with isolated talipes 
equinovarus, or isolated clubfoot, 
NOS 
•	3,029 infants with no major birth 
defects 
•	Births 1968–1980
•	5 counties in metropolitan Atlanta, 
GA 
Self-reported maternal 
smoking, from telephone 
interviews conducted in 
1981–1982
•	Clubfoot was associated with maternal 
smoking among those with no family 
history of clubfoot, OR = 1.34 (1.04–
1.72)
•	Much stronger association was found 
between clubfoot and maternal 
smoking among those with a first-
degree family history of clubfoot, OR = 
20.30 (7.9–52.17)
Honein et al. 
2001
•	U.S. natality data 
•	Study period: 1997–1998
•	45 states, New York City, and District 
of Columbia
Birth certificate report 
of number of cigarettes/
day during pregnancy by 
four categories: 1–5, 6–10, 
11–20, and ≥21 
•	Maternal smoking during pregnancy 
was associated with clubfoot, PR = 1.62 
(1.49–1.75)
•	Strongest effect at highest reported 
smoking level (≥21 cigarettes/day)
Skelly et al. 
2002
•	239 infants with idiopathic talipes 
equinovarus
•	356 unmatched controls selected by 
random-digit dialing 
•	Births on or after January 1, 1986, of 
children who were treated through 
May 1994




•	Smoking during pregnancy was 
associated with clubfoot
•	There was some evidence of a dose-
response effect, with the strongest 
effect for those smoking ≥20 cigarettes/
day, OR = 3.9 (1.6–9.2); a somewhat 
similar effect for those smoking 10–19 
cigarettes/day, OR = 3.1  
(1.7–5.8); and a weaker effect for those 
smoking <10 cigarettes/day, OR = 1.5 
(0.9–2.5)
•	No information was available on the 
timing of smoking during pregnancy
Cardy et al. 
2007
•	194 infants with talipes equinovarus 
and 60 controls
•	Children/parents recruited July 1993 
– July 1997
•	United Kingdom
•	Maternal smoking was more common 
among case- than control-mothers, but 
the association was not significant, OR 
= 1.37 (0.72–2.62)
Dickinson et al. 
2008
•	443 singleton infants diagnosed 
with isolated talipes equinovarus, or 
isolated clubfoot, NOS 
•	Random sample of 4,492 live births 




as reported on birth 
certificates; reliability 
of exposure assessed by 
matching to the North 
Carolina PRAMS, giving 
a Kappa = 0.77
•	Clubfoot was associated with any 
maternal smoking during pregnancy, 
OR = 1.40 (1.07–1.83)
•	There was no evidence of a dose-
response effect
•	No information was available on the 
timing of maternal smoking
Parker et al. 
2009
•	10 population-based birth defects 
surveillance programs 
•	6,139 infants with talipes 
equinovarus, or clubfoot, NOS, 
among 4,744,711 live births 
•	Births 2001–2005
Birth certificate data on 
smoking during pregnancy
•	Maternal smoking was associated with 
clubfoot, OR = 1.57 (1.45–1.70)
•	Case definition excluded infants 
with neural tube defects, lower limb 
defects, bilateral renal agenesis, and 
chromosomal abnormalities because 
the clubfoot was presumed to be 
secondary to these defects
•	Dose-response effect was observed
Reproductive Outcomes     S-301
The Health Consequences of Smoking —50 Years of Progress
Study by defect Design/population Definition of smoking Findings (95% CI)
Kancherla et al. 
2010
•	Study period: 1997–2005 
•	 Iowa
Smoking during pregnancy 
as reported on the birth 
certificate
•	Smoking was associated with clubfoot, 
POR = 1.5 (1.2–1.9)
Note: CI = confidence interval; NOS = not otherwise specified; OR = odds ratio; POR = prevalence odds ratio; PRAMS = Pregnancy 
Risk Assessment Monitoring System.
Table 9.4S Continued
Surgeon General’s Report
S-302     Chapter 9 Tables Supplement
Table 9.5S Summary of studies of maternal smoking and gastroschisis, 1999–2011
Study by defect Design/population Definition of smoking Findings (95% CI)





of smoking during 
antenatal visit typically 
at 10–12 weeks gestation
•	Maternal smoking was associated with 
isolated gastroschisis, OR 1.59 (1.00–2.54)
Stoll et al. 2001 •	Birth defects registry
•	1979–1998
•	France (Strasbourg)
•	No association between maternal smoking 
and gastroschisis, OR = 1.02 (0.44–2.37)
Werler et al. 
2003b
•	205 infants with gastroschisis
•	381 malformed controls
•	416 nonmalformed controls
•	Study period: June 1995–March 
1999
•	15 U.S. and Canadian cities 
Self-reported exposures 
in the first 2.5 months 
of pregnancy of mothers 
interviewed within 6 
months of delivery 
•	First-trimester smoking was associated 
with gastroschisis, OR = 1.5 (1.1–2.2)
•	Stronger effect was observed for 
the combination of vasoconstrictive 
medications and maternal smoking





Maternal tobacco use •	Maternal smoking was associated with 
gastroschisis, OR = 2.60 (1.48–4.55)
Lam et al. 
2006a
•	55 singleton infants with 
gastroschisis 
•	94 age-matched controls




3–6 months after 
delivery to ascertain 
periconceptional 
exposures 
•	Smoking more than 1 pack of cigarettes/
day had a borderline association with 
gastroschisis, OR = 2.0 (0.9–4.9)
•	Any smoking of marijuana was associated 
with gastroschisis, OR = 2.1 (1.0–4.4)
•	Study found some suggestion of an 
interaction between high exposure to 
carbon monoxide (from tobacco or 
marijuana) and low BMI
Chambers et al. 
2007




Tobacco use in the first 
trimester
•	Effect estimate was elevated, but there 
was no significant association between 





•	54 gastroschisis cases 
•	Study period: January 1990–
December 2001
•	3 Canadian provinces
Maternal smoking in the 
first trimester abstracted 
from prenatal care 
medical records
•	Study compared complicated gastroschisis 
cases (n = 17) with simple gastroschisis 
cases (n = 37)
•	Maternal smoking was more common 
in complicated gastroschisis but not 
significantly so, OR = 2.1 (0.6–7.2)
Draper et al. 
2008
•	Matched case-control study
•	144 infants with gastroschisis and 
432 control-mothers
•	 January 2001–August 2003
•	United Kingdom (3 regions)
•	After adjustment for other risk factors, 
maternal smoking was associated with 
gastroschisis, OR = 1.70 (1.1–2.6)
Feldkamp et al. 
2008
•	189 gastroschisis cases 
•	423,499 live-born infants without 
major defects




information on smoking 
during pregnancy
•	Maternal smoking was associated with 
gastroschisis after adjusting for maternal 
age, OR = 1.6 (1.1–2.3) 
•	Study excluded infants with ventral body 
wall defects, amniotic band sequence, and 
chromosomal abnormalities
Reproductive Outcomes     S-303
The Health Consequences of Smoking —50 Years of Progress
Table 9.5S Continued
Study by defect Design/population Definition of smoking Findings (95% CI)
Bird et al. 2009 •	NBDPS
•	Excluded infants with syndromes 
and single-gene disorders
•	485 infants with gastroschisis, 168 
with omphalocele
•	4,967 controls
•	 Infants born after October 1, 1997, 
and with an estimated date of 
delivery on or before December 31, 
2003
•	10 U.S. sites 
Self-reported maternal 
smoking from 1 month 
before conception 
to 3 months after 
conception, categorized 
as light (<1 pack/day), 
medium (1 pack/day), or 
heavy (>1 pack/day)
•	Heavy smokers were twice as likely to 
have an infant with gastroschisis, but 
finding not significant, OR = 2.08 (0.90–
4.78)
•	Heavy smoking was associated with 
omphalocele, OR = 4.26 (1.58–11.52)
Salemi et al. 
2009





pregnancy as reported on 
the birth certificate
•	 In the crude analyses, maternal smoking 
was associated with gastroschisis
•	After adjustment for maternal age, marital 
status, education, race/ethnicity, parity, 
and place of residence, there was no 
association, OR = 0.97 (0.73–1.28)
Werler et al. 
2009b
•	NBDPS
•	Excluded infants with syndromes 
and single-gene disorders
•	514 mothers of infants with 
gastroschisis
•	3,277 maternal age-matched 
controls 
•	 Infants born after October 1, 1997, 
and with an estimated date of 
delivery on or before December 31, 
2003
•	10 U.S. sites 
Self-reported smoking 
in the time period from 
2 weeks before the last 
menstrual period to 
14 weeks after the last 
menstrual period
•	Maternal smoking was associated with 
gastroschisis, OR = 1.5 (1.2–1.9)
•	There was no association between 
maternal smoking and gastroschisis 
among mothers <19 years of age
•	The strongest association between 
maternal smoking and gastroschisis was 
observed for mothers ≥25 years of age, 
OR = 3.0 (1.8–5.0)





Any smoking during 
pregnancy
•	Smoking during pregnancy was associated 
with gastroschisis, adjusted RR = 1.58 
(1.19–2.09)
Note: BMI = body mass index; CI = confidence interval; NBDPS = National Birth Defects Prevention Study; OR = odds ratio;  
RR = relative risk.
Surgeon General’s Report
S-304     Chapter 9 Tables Supplement
Table 9.6S Summary of studies of maternal smoking and congenital heart defects, 1999–2011
Study by defect Design/population Definition of smoking Findings (95% CI)
Källén 1999a •	3,384 infants with congenital 
heart defects (excluding those with 








reported at first antenatal 
visit
•	Significant associations with 
maternal smoking were observed for 
transposition of the great arteries, 
OR = 1.32 (1.02–1.71); atrial septal 
defects, OR = 1.63 (1.04–2.57); and 
full-term infants with PDA, OR = 1.30 
(1.05–1.62).
Woods and Raju 
2001
•	TriHealth Hospital system births
•	18,016 live births; examined 22 
categories of birth defects




smoking during pregnancy, 
collected at the time of 
admission for delivery 
(prior to actual delivery)
•	Congenital heart defects were more 
common among smoking mothers 
than nonsmoking mothers, RR = 1.56 
(1.12–2.19) (p <0.01)
•	No other defect categories were 
significantly associated (p ≤0.01) with 
maternal smoking
Botto et al. 
2001
•	Case-control study
•	905 infants with nonsyndromic 






•	Maternal smoking was not associated 
with all congenital heart defects 




•	55 infants with single ventricle
•	3,572 control infants
•	Study period: 1981–1989
•	District of Columbia, Maryland, and 
some counties in Northern Virginia 
Maternal and paternal 
smoking (none, 1–20, 
20–39, and ≥40 cigarettes/
day), collected by interview 
after the pregnancy 
•	Paternal smoking was associated 
with single ventricle, and there was 
some evidence of a dose-response 
effect (ORs were 1.0, 1.9, and 3.7 for 
increasing smoking dose, p for trend = 
0.02) based on 6 exposed cases
•	No significant association was found 





•	76,768 pregnancies resulting in 






smoking and use of 
nicotine substitutes (gum, 
patches, inhalers), collected 
by interview during 
pregnancy
•	A modest but significant association 
was found between maternal smoking 
and congenital heart defects, OR = 
1.20 (1.03–1.40)
Malik et al. 
2008
•	NBDPS
•	Excluded infants with syndromes and 
single-gene disorders
•	3,067 congenital heart defects 
•	3,947 controls
•	Study period: October 1997–
December 2002
•	8 U.S. sites 
Self-reported smoking 
in the month before 
pregnancy through the 
first trimester, categorized 
as light (<1/2 pack/day), 
medium (1/2–1 pack/day), 
and heavy (≥25 cigarettes/
day), reported by interview 
after pregnancy
•	Light, medium, and heavy smoking 
were all associated with septal heart 
defects and especially atrial septal 
defects
Reproductive Outcomes     S-305
The Health Consequences of Smoking —50 Years of Progress
Table 9.6S Continued
Study by defect Design/population Definition of smoking Findings (95% CI)
Grewal et al. 
2008
•	Case-control study
•	320 infants with conotruncal heart 
defects and 639 controls
•	Births from selected counties (Los 
Angeles, San Francisco, and Santa 
Clara)
•	Births July 1999–June 2004
•	California
Self-reported smoking 
during the first month 
of pregnancy, data 
collected after pregnancy 
completion; smoking 
categorized as >5 or 
≤5 cigarettes/day for the 
first month of pregnancy
•	Smoking in the first month of 
pregnancy was not associated with 




•	187 newborns with congenital heart 
defects




Maternal smoking during 
pregnancy and duration of 
smoking prior to pregnancy
•	Smoking during pregnancy was 
associated with congenital heart 
defects, OR = 2.45 (1.43–4.20), and 
after adjusting for occupation and 
education, the OR was reduced, 1.48 
(0.82–2.67)
•	Study found a stronger association for 
mothers who had smoked longer (≥3 
years) prior to pregnancy
Kučienė and 
Dulskienė 2010 
•	261 cases with congenital heart 
defect from newborns’ register 
database




smoking before and during 
the first trimester and self-
reported paternal smoking 
•	 Increased risk of congenital heart 
septal defects was associated with 
maternal smoking, AOR = 2.20 
(1.01–4.79); paternal smoking, AOR 
= 1.45 (1.03–2.03),; and both parents 





Maternal smoking, on the 
basis of questionnaire after 
pregnancy
•	Smoking during pregnancy was not 
associated with congenital heart 
defects (p = 0.47)
Alverson et al. 
2011 
•	Baltimore-Washington Infant Study
•	2,525 infants with congenital heart 




cigarette smoking during 
first trimester
•	Smoking during first trimester was 
associated with increased risk of 
secundum-type atrial septal defects, 
OR = 1.36 (1.04–1.78); pulmonary 
valve stenosis, OR = 1.35 (1.05–1.74); 
truncus arteriosus, OR = 1.90 (1.04–
3.45); and l-transposition of the great 
arteries, OR = 1.79 (1.04–3.10)
•	Associations were not observed for 
maternal smoking and most other 
congenital heart defects 
Cresci et al. 
2011 
•	360 infants with congenital heart 
defects
•	360 infants without defects from 
a pediatric cardiac center and 




and paternal smoking at 
conception
•	Paternal smoking was associated with 
an increased risk of congenital heart 
defects, OR = 1.7 (1.1–2.6), but there 
was no significant association for 
maternal smoking, OR = 1.2 (0.7–1.8)
Surgeon General’s Report
S-306     Chapter 9 Tables Supplement
Study by defect Design/population Definition of smoking Findings (95% CI)
Karatza et al. 
2011
•	157 neonates with congenital heart 
defects
•	208 unaffected neonates 
•	Study period: June 2006–June 2009
•	Greece 
Self-reported maternal 
smoking (1 month before 
conception through 
first trimester) obtained 
by interview prior to 
echocardiographic exam of 
the infant 
•	Congenital heart defects were 
identified in 61% of the neonates 
whose mother smoked and 36% of 
neonates whose mother did not smoke 
(p <0.001)
•	 In the adjusted analyses, maternal 
smoking was associated with 
congenital heart defects, OR = 2.74 
(1.66–4.53)
Baardman et al. 
2012
•	797 cases, born with isolated 
nonsyndromic congenital heart 
defect and identified from a 
population-based birth defects 
registry 
•	322 infants/fetuses with 
chromosomal anomalies but without 




smoking before and 
through first trimester of 
pregnancy
•	Periconceptional smoking was 
associated with congenital heart 
defects among women with a high 
BMI, AOR = 2.65 (1.20–5.87)
•	Significant and elevated AORs were 
observed for septal heart defects and 
outflow tract defects based on the 
interaction between smoking and high 
BMI
Mateja et al. 
2012
•	Data from PRAMS, linked to state 
birth certificates
•	237 infants with a congenital 
heart defect, as indicated on birth 
certificate, with no indication of 
Down syndrome
•	948 controls with no indication of 
any congenital defect




Self-reported smoking 3 
months before pregnancy
•	Smoking during pregnancy was not 
associated with congenital heart 
defects
•	There was a significant interaction 
between exposure to alcohol and 
smoking before pregnancy (p <0.01)
Note: AOR = adjusted odds ratio; BMI = body mass index; CI = confidence interval; NBDPS = National Birth Defects Prevention 
Study; OR = odds ratio; PDA = Patent ductus arteriosus; PRAMS = Pregnancy Risk Assessment Monitoring System; RR = relative 
risk. 
Table 9.6S Continued
Reproductive Outcomes     S-307
The Health Consequences of Smoking —50 Years of Progress
Table 9.7S Summary of studies of maternal smoking and craniosynostosis, 1999–2011
Study by defect Design/population Definition of smoking Findings (95% CI)
Källén 1999b •	304 infants with craniosynostosis 
and no chromosomal abnormality 





pregnancy at prenatal 
consultations with midwife
•	Smoking was associated with 
craniosynostosis, OR = 1.45 (1.13–1.87), 
but the effect was limited to those with 
an isolated defect (i.e., they had no 
other major birth defect unrelated to 
craniosynostosis)
•	Strongest effect was found for sagittal 
craniosynostosis
•	Study found some evidence for a dose-






•	5 central counties of 
metropolitan Atlanta, Georgia 
Reported smoking at any 
time in the first 3 months 
of pregnancy
•	Smoking in the first trimester was 
associated with isolated craniosynostosis, 




•	531 infants with craniosynostosis
•	5,008 controls
•	Study period: 1997–2003
•	10 U.S. sites 
Self-reported number 
of cigarettes/day in the 
month before pregnancy, 
each month of the first 
3 months of pregnancy, 
and the second and third 
trimesters of pregnancy
•	There was a borderline association with 
heavy maternal smoking (≥15 cigarettes/
day) for mothers still smoking in the third 
month of pregnancy, OR = 1.6 (0.9–2.6)
•	Study found some evidence for a stronger 
effect of maternal smoking among those 
without exposure to folic acid until very 
late in pregnancy
Butzelaar et al. 
2009
•	Surgical sagittal synostosis 
patients in 1 hospital 
•	Study period: 2006
•	The Netherlands 
Smoking during pregnancy •	Smoking among case mothers did not 
differ from that reported by the general 
population
Note: CI = confidence interval; NBDPS = National Birth Defects Prevention Study; OR = odds ratio.
Surgeon General’s Report
S-308     Chapter 9 Tables Supplement
Table 9.8S Summary of studies of maternal smoking and anorectal atresia, 1999–2011
Study by defect Design/population Definition of smoking Findings (95% CI)




Prenatal assessment of 
smoking during antenatal 
visit typically at 10–12 weeks 
gestation
•	Maternal smoking was associated 
with isolated anal atresia, OR = 
1.45 (1.11–1.90)
Honein et al. 
2001
•	U.S. natality data 
•	Study period: 1997–1998
•	45 states, New York City, and District 
of Columbia
•	564 infants with rectal atresia/stenosis 
indicated on birth certificate
Birth certificate report of 
number of cigarettes/day 
during pregnancy by four 
categories: 1–5, 6–10, 11–20, 
and ≥21 
•	Maternal smoking during 
pregnancy was modestly 
associated with anal atresia 
but not significant, PR = 1.19 
(0.94–1.50)
•	No evidence of dose-response 
effect
Miller et al. 
2009
•	NBDPS
•	464 infants with anorectal atresia (216 
of the defects were isolated) 
•	4,940 controls




smoking, defined as smoking in 
the month before conception 
or first 3 months of pregnancy, 
interviewed after pregnancy; 
exposure to environmental 
tobacco smoke defined as 
reported exposure at home or 
work in the same time period
•	Any maternal smoking had 
borderline association with 
anorectal atresia, OR = 1.2 
(1.0–1.5)
•	Exposure to secondhand smoke 
at home and work was associated 
with anorectal atresia, OR = 2.3 
(1.2–4.1)
Van Rooij et al. 
2010 
•	Radbound University, Pediatric 
Surgery Department
•	Children born between January 1996 
and April 2008 who were treated for 
anorectal malformation (85 cases)
•	650 controls who were boys with 
persistent middle ear infections and 
were participating in another study
•	Study period: 1996–2008
•	The Netherlands
Maternal smoking from 3 
months before conception and 
during pregnancy; paternal 
smoking from 3 
months before pregnancy to 
conception 
•	Paternal smoking was 
significantly associated with 
increased risk of anorectal 
malformations: crude, OR = 1.8 
(1.1–2.9)
•	Maternal smoking was not 
associated with anorectal 
malformations
Note: CI = confidence interval; NBDPS = National Birth Defects Prevention Study; OR = odds ratio; PR = prevalence ratio.
Reproductive Outcomes     S-309
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S-342     Chapter 9 Tables Supplement
Table 9.16S Experimental studies of the association between smoking and erectile dysfunction
Study Design/population Stimulus Findings
Gilbert et 
al. 1986
•	Humans: randomized controlled trial with 42 
smokers
•	18–44 years of age
Visual sexual 
stimulation
•	High-nicotine cigarettes reduced 
the extent to which penile diameter 
increased
Glina et al. 
1988
•	Humans: acute experiment with 12 smokers
•	22–65 years of age
Erection 
pharmocostimulation





•	Animals: acute experiment using dogs Cavernous nerve 
electrostimulation
•	 Inhalation of cigarette smoke reduced 
erectile parameters
Xie et al. 
1997
•	Animals: chronic experiment using rats Cavernous nerve 
electrostimulation
•	 Inhalation of cigarette smoke did not 
alter erection parameters
Guay et al. 
1998
•	Humans: acute experiment with 10 smokers
•	32–62 years of age
Sleep-related erection •	Cessation of cigarette smoking 
improved erectile parameters
Reproductive Outcomes     S-343
The Health Consequences of Smoking —50 Years of Progress
Table 9.17S Cross-sectional studies of the association between smoking and the risk of erectile dysfunction
Study Design/population
Prevalence (%) of erectile dysfunction by 
smoking status p Value
Feldman et al. 1994a •	U.S. residents
•	40–70 years of age
•	Studied during 1987–1989
•	Boston, MA
•	Never and former: 9.3
•	Current: 11.0 >0.200
Mannino et al. 1994a •	U.S. veterans






Feldman et al. 2000c •	U.S. residents
•	40–70 years of age
•	Studied during 1987–1997
•	Boston, MA
•	Never and former: 14.0
•	Current: 24.0
0.03
Kleinman et al. 2000 •	U.S. men







Parazzini et al. 2000a •	 Italian men






Blanker et al. 2001a •	Dutch men
•	50–78 years of age
•	Studied during 1995–1998
•	Never and former: NR
•	Current: NR
NR
Martin-Morales et al. 
2001a
•	Spanish men
•	25–70 years of age
•	Studied during 1998–1999
•	Never and former: NR
•	Current: NR
NR
Bacon et al. 2003a •	U.S. male health professionals






Shiri et al. 2005 •	Finnish men













•	>20 cigarettes/day: 51.2 
NR
Millett et al. 2006a •	Australian men







He et al. 2007 •	Chinese men
•	35–74 years of age
•	Studied during 2000–2001
•	Smokers vs. never smokers:
•	35–44 years of age: 6.4 vs. 4.6
•	45–54 years of age: 17.8 vs. 14.8
•	55–64 years of age: 44.0 vs. 35.6





S-344     Chapter 9 Tables Supplement
Study Design/population
Prevalence (%) of erectile dysfunction by 
smoking status p Value
Kupelian et al. 2007 •	U.S. men















Table 10.1S Summary of evidence from case-control studies on the association between smoking and age-related 
macular degeneration (AMD)     S-347
Table 10.2S Summary of evidence from cross-sectional studies on the association between smoking and age-related 
macular degeneration (AMD)     S-356
Table 10.3S Summary of evidence from prospective cohort studies on the association between smoking and age-
related macular degeneration (AMD)     S-362
Table 10.4S Summary of evidence from other types of studies on the association between smoking and age-related 
macular degeneration (AMD)     S-370
Table 10.5S Studies on the association between active smoking and dental caries     S-374
Table 10.6S Studies on exposure to tobacco smoke and dental caries     S-379
Table 10.7S Studies on smoking and failure of dental implants     S-383
Table 10.8S Characteristics of studies included in the meta-analysis on smoking and diabetes     S-393
Table 10.14S Studies on the association between smoking and rheumatoid arthritis (RA) risk     S-400
Table 10.15S Studies on the association between smoking and rheumatoid arthritis (RA) severity     S-403
Table 10.16S Studies on the association between smoking and rheumatoid arthritis (RA) treatment response     S-405
Table 10.17S Studies on the association between smoking and systemic lupus erythematosus (SLE) risk     S-406
Table 10.18S Studies on the association between smoking and systemic lupus erythematosus (SLE) severity and 
manifestations     S-408
Table 10.19S Studies on smoking and systemic lupus erythematosus (SLE) treatment response     S-409
Table 10.20S Characteristics of the studies on the effects of current smoking on Crohn’s disease or ulcerative colitis     
S-410
Table 10.21S Characteristics of the studies on the effects of former smoking on Crohn’s disease or ulcerative colitis     
S-427

Other Specific Outcomes     S-347
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•	12 years of age at baseline (7 grade)
•	Falkenberg, Sweden
•	3-year follow-up
•	Mean DMFS (±SD) increment by 8th-grade smoking status:
 – Smoker: 7.7 (±4.7), p <0.001
 – Nonsmoker: 1.9 (±4.7)
•	DMFS increment ≥1 for smokers: OR = 4.1 (1.0–18.9)
Birnboim-
Blau et al. 
2006
•	Cross-sectional
•	581 male army recruits
•	17–26 years of age
•	 Israel
•	DT (mean):
 – Smoker: 2.31
 – Nonsmoker: 1.48
 – p <0.0001 (t-test)
•	MT (mean):
 – Smoker: 0.40
 – Nonsmoker: 0.19
 – p = 0.0012 (t-test)
•	FT (mean):
 – Smoker: 2.73
 – Nonsmoker: 3.57
 – p = 0.0049 (t-test)
•	DMFT (mean): 
 – Smoker: 5.44
 – Nonsmoker: 5.25
 – p = 0.6000 (t-test)




•	Prevalence of dental caries:
 – Current smoker: 91.48%
 – Former smoker: 92.83%
 – Never smoker: 91.19%
•	Prevalence of untreated dental caries:
 – Current smoker: 39.26%
 – Former smoker: 19.67%
 – Never smoker: 20.56%
•	DT (mean):
 – Current smoker: 1.42
 – Former smoker: 0.53
 – Never smoker: 0.51
•	MT (mean):
 – Current smoker: 4.12
 – Former smoker: 2.30
 – Never smoker: 1.83
•	FT (mean):
 – Current smoker: 5.90
 – Former smoker: 7.73
 – Never smoker: 7.31
•	DMFT (mean):
 – Current smoker: 11.44
 – Former smoker: 10.55
 – Never smoker: 9.65
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•	Prevalence of untreated dental caries:
 – Current smoker: 52.4%
 – Former smoker: 42.3%
 – Never smoker: 33.9%
•	AOR for untreated dental caries (adjusted for frequency of brushing, 
BMI, alcohol consumption, and intake of vitamins C and E):
 – Current smoker: 1.67 (1.28–2.20)
 – Former smoker: 1.25 (0.77–2.04)




•	824 male truck drivers, 20–65 years 
of age (mean age = 35.5 years)
•	Mexico City, Mexico
•	DT (mean):
 – Current smoker: 3.97
 – Former smoker: 3.94
 – Nonsmoker: 4.13
 – Tukey-Kramer p trend = 0.85
•	MT (mean):
 – Current smoker: 1.65
 – Former smoker: 2.24
 – Nonsmoker: 1.40
 – Tukey-Kramer p trend < 0.01
•	FT (mean):
 – Current smoker: 3.16
 – Former smoker: 3.66
 – Nonsmoker: 3.02
 – Tukey-Kramer p trend = 0.27
•	DMFT (mean):
 – Current smoker: 8.80
 – Former smoker: 9.86
 – Nonsmoker: 8.55




•	1,096 randomly selected adults
•	18–67 years of age
•	 Irbid, Jordan
•	DS (mean):
 – Smoker: 7.27
 – Nonsmoker: 6.01
 – Mann-Whitney p trend = 0.05
•	MS (mean): 
 – Smoker: 25.18
 – Nonsmoker: 19.45
 – Mann-Whitney p trend = 0.05
•	FS (mean):
 – Smoker: 6.75
 – Nonsmoker: 8.33
 – Mann-Whitney p trend = 0.05
•	DFS (mean):
 – Smoker: 14.02
 – Nonsmoker: 14.24
 – Mann-Whitney p trend = 0.05
•	DMFS (mean):
 – Smoker: 39.20
 – Nonsmoker: 33.79
 – Mann-Whitney p trend = 0.05
•	Smoking status was a significant (p <0.005) independent variable in 
a multiple linear regression model of DMFS that also included age, 
frequency of dental flossing, family income, urban/rural residence, 
education level, and frequency of toothbrushing.
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•	644 randomly selected adults
•	20–25 years of age
•	South Australia
•	Precavitated DS (mean):
 – Current smoker: 3.07
 – Not current smoker: 2.19
•	Cavitated DS (mean):
 – Current smoker: 1.43
 – Not current smoker: 0.65
 – p <0.05 (ANOVA)
•	D3MFS (mean):
 – Current smoker: 6.26
 – Not current smoker: 5.96
•	Current smoking status was also significantly associated (p <0.01) 
with DS in a multiple linear regression model that was adjusted for 
government benefits, employment status, usual reason for dental visit, 
public/private site for last dental visit, frequency of toothbrushing, and 





•	30–69 years of age
•	Kochi, India
•	DT (mean):
 – Regular smoker: 6.44
 – Occasional smoker: 3.60
 – Former smoker: 5.50
 – Nonsmoker: 5.10
 – p <0.001 (Kruskal-Wallis one-way ANOVA)
•	MT (mean):
 – Regular smoker: 1.90
 – Occasional smoker: 1.57
 – Former smoker: 1.62
 – Nonsmoker: 1.53
 – p trend = 0.529 (Kruskal-Wallis one-way ANOVA)
•	FT (mean):
 – Regular smoker: 3.29
 – Occasional smoker: 1.97
 – Former smoker: 3.23
 – Nonsmoker: 2.33
 – p <0.001 (Kruskal-Wallis one-way ANOVA)
•	DMFT (mean):
 – Regular smoker: 11.63
 – Occasional smoker: 7.14
 – Former smoker: 10.35
 – Nonsmoker: 8.96
 – p <0.001 (Kruskal-Wallis one-way ANOVA)
Al-Habashneh 
et al. 2009 
•	Cross-sectional
•	560 periodontal patients
•	16–35 years of age
•	 Irbid, Jordan
•	Chronic gingivitis, DMFT (mean):
 – Smoker: 8.02
 – Nonsmoker: 5.39
 – p <0.05 (t-test)
•	Chronic periodontitis, DMFT (mean):
 – Smoker: 12.87
 – Nonsmoker: 9.59
 – p <0.05 (t-test)
•	Aggressive periodontitis, DMFT (mean):
 – Smoker: 5.03
 – Nonsmoker: 3.00
 – p <0.05 (t-test)
Table 10.5S Continued
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Du et al. 2009 •	Cross-sectional
•	1,080 adults, 35–44 years of age
•	1,080 adults, 65–74 years of age
•	Hubei Province, China
•	Prevalence of experience with root surface caries among persons with 
gingival recession:
 – Current smoker: 38.6%
 – Former smoker: 30.7%
 – Never smoker: 29.8%
•	AOR for root surface caries among persons with gingival recession 
(adjusted for age, ethnicity, tea drinking, dental visits, and annual 
family income):
 – Current smoker: 1.76 (1.18–2.63)
 – Former smoker: 1.39 (1.10–1.75)
 – Never smoker: 1.00 (reference)
Iida et al. 
2009 
•	Cross-sectional 
•	Nationally representative sample 
•	5,110 females
•	15–44 years of age
•	United States
•	Prevalence of untreated caries: 
 – Current smoker: 34.6%
 – Former smoker: 18.3%
 – Never smoker: 20.3%
•	DMFS (mean):
 – Current smoker: 25.5
 – Former smoker: 16.5
 – Never smoker: 16.1
•	AOR for untreated caries (adjusted for age, race/ethnicity, country of 
birth, poverty status, education level, health insurance status, marital 
status, number of live births, BMI, alcohol consumption, time since 
last dental visit, and reason for last dental visit):
 – Current smoker: 1.82 (1.23–2.70)
 – Former smoker: 0.99 (0.65–1.52)
 – Never smoker: 1.00 (reference)
Skudutyte-
Rysstad et al. 
2009 
•	Cross-sectional
•	Random sample of 149 adults
•	35 years of age
•	Oslo, Norway
•	Number of sound teeth (mean):
 – Current smoker: 17.4
 – Former smoker: 16.0
 – Never smoker: 17.5
•	Prevalence of decay:
 – Current smoker: 50%
 – Former smoker: 32%
 – Never smoker: 14%
•	AOR for decay (adjusted for family income, frequency of 
toothbrushing, pattern of dental visits, and time since last dental visit): 
 – Current smoker: 4.5 (1.6–12.6)
 – Former smoker: 2.8 (1.0–8.2)
 – Never smoker: 1.00 (reference)
Ditmyer et al. 
2010 
•	Case-control
•	Cases: 1,576 adolescents, 12–19 
years of age, with ≥4 DMFT
•	Controls: 1,392 adolescents, 12–19 
years of age, with no dental caries 
•	Nevada
•	Smoking status of adolescent cases:
 – Currently smoke: 372 (23.6%)
 – Currently do not smoke: 1,204 (76.4%)
•	Smoking status of adolescent controls:
 – Currently smoke: 215 (15.4%)
 – Currently do not smoke: 1,177 (84.6%)
•	AOR for ≥4 DMFT (adjusted for race/ethnicity, age, dental insurance 
status, fluoridation status, exposure to secondhand smoke, and 
presence of dental sealants): 1.85 (1.68–2.06)
Table 10.5S Continued
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•	18–25 years of age
•	Udaipur, India
•	DT (mean):
 – Smoker: 4.05
 – Nonsmoker: 2.82
 – p <0.0001 (t-test)
•	MT (mean):
 – Smoker: 0.27
 – Nonsmoker: 0.06
 – p <0.0001 (t-test)
•	FT (mean):
 – Smoker: 1.69
 – Nonsmoker: 1.19
 – p trend = 0.004 (t-test)
•	DMFT (mean):
 – Smoker: 6.01
 – Nonsmoker: 4.08
 – p <0.0001 (t-test)




•	60–94 years of age
•	Chiba, Japan
•	Smoking status was not associated with the number of decayed root 
surfaces








 – Heavy smoker: 1.1
 – Light smoker: 0.8
 – Nonsmoker: 0.6
 – p trend = 0.01 (Kruskal-Wallis)
•	MS (mean):
 – Heavy smoker: 2.5
 – Light smoker: 2.5
 – Nonsmoker: 2.3
 – p >0.05 (Kruskal-Wallis)
•	FS (mean):
 – Heavy smoker: 7.9
 – Light smoker: 7.6
 – Nonsmoker: 7.4
 – p >0.05 (Kruskal-Wallis)
•	DMFS (mean):
 – Heavy smoker: 11.5
 – Light smoker: 11.3
 – Nonsmoker: 9.9
 – p trend = 0.04 (Kruskal-Wallis)
Notes: ANOVA = analysis of variance; AOR = adjusted odds ratio; BMI = body mass index; CI = confidence interval; DFS = decayed 
or filled permanent tooth surfaces; DMFS = decayed, missing, or filled permanent tooth surfaces; D3MFS = cavitated, decayed, 
untreated, missing, or filled permanent tooth surfaces; DMFT = decayed, missing, or filled permanent teeth; DS = decayed permanent 
tooth surfaces; DT = decayed permanent teeth; FS = filled permanent tooth surfaces; FT = filled permanent teeth; MS = missing 
permanent tooth surfaces; MT = missing permanent teeth; OR = odds ratio; SD = standard deviation.
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•	Nationally representative sample 
•	749 children
•	3–4.5 years of age
•	United Kingdom
•	Prevalence of dental caries by parental smoking status:
 – Neither parent: 21%
 – Mother only: 38% (p<0.001)a
 – Father only: 25% (p not significant)a
 – Both parents: 31% (p <0.05)a
 – Either parent: 33% (p <0.001)a
•	dmft (mean) by parental smoking status:
 – Neither parent: 0.8
 – Mother only: 1.8
 – Father only: 0.8
 – Both parents: 1.5
 – Either parent: 1.3
•	Prevalence of dental caries by household social class (nonmanual or 
manual occupation) and mothers’ smoking status:
 – Nonmanual, smoker: 32% (p <0.01)b
 – Nonmanual, nonsmoker: 18%
 – Manual, smoker: 38% (p <0.05)b
 – Manual, nonsmoker: 26%
•	dmft (mean) by household social class and mothers’ smoking status:
 – Nonmanual, smoker: 1.4
 – Nonmanual, nonsmoker: 0.6 
 – Manual, smoker: 1.9
 – Manual, nonsmoker: 1.0 
•	AOR for mothers’ smoking and dental caries in child (adjusted for 
child’s age and social class of head of household): 1.54 (1.07–2.21)
Aligne et al. 
2003 
•	Cross-sectional 
•	Nationally representative sample 
•	3,531 children
•	4–11 years of age
•	United States
•	Prevalence of decayed or filled tooth surfaces of deciduous teeth by 
serum cotinine level (ng/mL):
 – <0.2 (decayed): 18.2% (reference)
 – 0.2–10 (decayed): 31.7% (p <0.001)
 – <0.2 (filled): 29.2% (reference)
 – 0.2–10 (filled): 36.5% (p = 0.01)
•	Prevalence of decayed or filled tooth surfaces of permanent teeth by 
serum cotinine level (ng/mL):
 – <0.2 (decayed): 7.4% (reference)
 – 0.2–10 (decayed): 10.4% (p = 0.07)
 – <0.2 (filled): 19.7% (reference)
 – 0.2–10 (filled): 18.3% (p = 0.59)
•	AOR for decayed deciduous teeth associated with serum cotinine level 
(ng/mL):
 – <0.05: 1.0 (reference)
 – 0.05–<0.2: 1.3 (0.8–2.4)
 – 0.2–1.0: 2.2 (1.3–3.6)
 – >1.0: 2.3 (1.4–3.0)
•	AOR for filled deciduous teeth associated with serum cotinine level (ng/
mL):
 – <0.05: 1.0 (reference)
 – 0.05–<0.2: 1.1 (0.7–1.8)
 – 0.2–1.0: 1.6 (1.0–2.4)
 – >1.0: 1.5 (1.0–2.3)
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•	4–7 years of age
•	 Iowa
•	Prevalence and RR of dental caries in primary dentition by SES and 
presence of regular smoker in household (reference: no smoker in 
home):
 – Low SES. Smoker in home: 48%, RR = 1.50 (0.95–2.37); no smoker 
in home: 32%
 – Middle SES. Smoker in home: 52%, RR = 2.15 (1.35–3.45); no 
smoker in home: 24%
 – High SES. Smoker in home: 33%, RR = 1.66 (0.64–4.33); no smoker 
in home: 20%
 – All. Smoker in home: 44%, RR = 1.74 (1.27–2.37); no smoker in 
home: 25%
•	AOR for caries in primary dentition and presence of regular smoker in 
household (adjusted for age, frequency of toothbrushing, total ingested 
fluoride, and SES): 3.38 (1.68–6.79)
Tanaka et al. 
2006 
•	Cross-sectional 
•	Nationally representative sample 
•	925 children
•	1–14 years of age
•	 Japan 
•	Prevalence of decayed or filled teeth and AOR (adjusted for age, 
gender, region, frequency of toothbrushing, experience with topical 
fluoride application, and BMI) for outcome by presence of smoking in 
household (reference: no smoker in home):
 – Decayed and/or filled teeth. Smoker in home: 63.4%, AOR = 1.26 
(0.93–1.69); no smoker in home: 59.6%
 – Decayed teeth. Smoker in home: 40.5%, AOR = 1.34 (1.02–1.76); no 
smoker in home: 33.6%
 – Filled teeth. Smoker in home: 49.1%, AOR = 1.03 (0.76–1.40); No 
smoker in home: 49.4%
Ayo-Yusuf et 
al. 2007 
•	Cross-sectional representative sample 
•	1,873 8th-grade students
•	12–19 years of age
•	Limpopo Province, South Africa
•	Prevalence and AOR for decayed second permanent molars by exposure 
to secondhand smoke:
 – Smoker in home: 23.4%, AOR = 2.02 (1.22–3.33)




•	Nationally representative sample 
•	3,189 children
•	2–5.9 years of age
•	United States
•	Prevalence and AOR for ≥1 dft by number of smokers in the home 
(adjusted for child’s gender, age, and race/ethnicity; maternal age at 
birth of child; fluoride supplementation status; carbohydrate intake; 
education level of head of household; household income poverty ratio; 
frequency of dental visits; duration of bottle feeding; low birth weight; 
and preterm birth): 
 – No smokers in home: 17.6%, AOR = 1.00 (reference)
 – 1 or 2 smokers in home: 28.6%, AOR = 1.42 (1.13–1.78)
 – >2 smokers in home: 24.6%, AOR = 1.39 (1.02–1.89)




•	4–6 years of age
•	Turkey
•	Prevalence of dental caries and mean dmft by status of smoking in the 
household:
 – No smoking in home: 65.6%, 4.64
 – Smoking in home: 89.9%, 10.58
•	Mean dmft by number of cigarettes smoked/day by members of the 
household:
 – <10 cigarettes/day: 5.20
 – 10–20 cigarettes/day: 9.77
 – >20 cigarettes/day: 16.77
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•	3 years of age, attending a public 
health center
•	Hokkaido, Japan 
•	Adjusted mean number of decayed teeth, prevalence of decayed teeth, 
and AOR for having decayed teeth by smoking status of parents 
(adjusted for gender, order of birth, main type of drink, frequency 
of sugar-containing snacks, daily toothbrushing by parents, use of 
fluoridated toothpaste, and residential location):
 – Neither parent smokes: 1.2 (mean), 25.6%, AOR = 1.00 (reference)
 – Only father smokes: 1.6 (mean), 35.3%, AOR = 1.52 (1.01–2.30)
 – Only mother smokes: 2.1 (mean), 45.7%, AOR = 2.25 (1.51–3.37)
Leroy et al. 
2008 
•	Cross-sectional
•	Representative samples: 1,250 
children, 3 years of age; 1,283 
children, 5 years of age
•	Flanders (Flemish Region), Belgium 
•	For children, 3 years of age, prevalence and AOR of experience with 
dental caries by family smoking status:
 – Current smoker: 10.3%, AOR = 1.98 (0.68–5.76)
 – Former smoker: 5.9%, AOR = 1.71 (0.30–9.65)
 – Never smoker: 4.9%, AOR = 1.00 (reference)
•	For children, 5 years of age, prevalence and AOR of experience with 
dental caries by family smoking status:
 – Current smoker: 41.8%, AOR = 3.36 (1.49–7.58)
 – Former smoker: 24.8%, AOR = 0.55 (0.19–1.65)
 – Never smoker: 25.2%, AOR = 1.00 (reference)




•	3 years of age
•	Fukuoka City, Japan
•	Prevalence and AOR of dental caries by exposure to secondhand smoke 
at home (p value for linear trend = 0.006):
 – Current smoker: 25%, AOR = 1.25 (1.04–1.50)
 – Former smoker: 24%, AOR = 1.23 (0.88–1.71)
 – Never smoker: 17.8%, AOR = 1.00 (reference)
•	Prevalence and AOR of dental caries by pack-months of exposure to 
secondhand smoke at home:
 – ≥18: 27.1%, AOR = 1.33 (1.09–1.63)
 – 0.1–17.9: 22.6%, AOR = 1.16 (0.93–1.44)
 – None: 17.8%, AOR = 1.00 (reference)
Christensen 
et al. 2010 
•	Cross-sectional
•	2,168 children and adolescents
•	5, 12, and 15 years of age
•	Denmark
•	Mean number of DMFS+dmfs and AOR for DMFS+dmfs >1 by smoking 
status of parents/respondents:
 – Smoker: 2.8 (mean) (p <0.001); AOR = 1.35 (p <0.05)




•	Cases: 2,115 adolescents; 12–19 years 
of age, with ≥4 DMFT
•	Controls: 2,035 adolescents; 12–19 
years of age, with no dental caries 
•	Nevada
•	Number and percentage of cases and controls exposed and not exposed 
to secondhand smoke:
 – Exposed: 871 cases (41.2%); 565 controls (27.8%)
 – Not exposed: 1,244 cases (58.8%); 1,470 controls (72.2%)
•	AOR (adjusted for race/ethnicity, age, dental insurance status, 
fluoridation status, smoking status, and presence of dental sealants): 
1.42 (1.03–1.53) 
Surgeon General’s Report
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•	6–15 years of age
•	Okinawa, Japan 
•	Prevalence of decayed or filled teeth and adjusted PRs by status of 
smoking in household (p <0.0001):
 – Never smoker: 79.3%, PR = 1.00 (reference)
 – Former smoker: 83.4%, PR = 1.03 (1.00–1.05)
 – Current smoker <15 cigarettes/day: 84.4%, PR = 1.04 (1.02–1.05)
 – Current smoker ≥15 cigarettes/day: 85.5%, PR = 1.04 (1.03–1.06)
•	Prevalence of decayed or filled teeth and adjusted PRs by pack-years of 
secondhand smoking in household (p <0.0001):
 – None: 79.3%, 1.00 (reference)
 – 0.1–2.9: 84.3%, PR = 1.03 (1.02–1.05)
 – 3.0–6.9: 84.1%, PR = 1.03 (1.01–1.05)
 – ≥7.0: 85.3%, PR = 1.04 (1.03–1.06)
Notes: AOR = adjusted odds ratio; BMI = body mass index; CI = confidence interval; dft = decayed or filled primary teeth; dmfs = 
decayed, missing, or filled primary tooth surfaces; DMFS = decayed, missing, or filled permanent tooth surfaces; dmft = decayed, 
missing, or filled primary teeth; ng/mL = nanogram per milliliter; pack-years = the number of years of smoking multiplied by the 
number of packs of cigarettes smoked per day; PR = prevalence ratio; RR = relative risk; SES = socioeconomic status. 
ap value, χ2 test compared households where neither parent smoked.
bp value, χ2 test compared prevalence of caries among children by mother’s smoking status in each stratum of social class.
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S-400     Chapter 10 Tables Supplement
Table 10.14S Studies on the association between smoking and rheumatoid arthritis (RA) risk
Study Design/ population Tobacco exposure Outcome Findings
Heliövaara 
et al. 1993





Diagnosis of RA •	RR of seropositive RA was 2.6 (95% CI, 1.3–5.3) 
in male ex-smokers and 3.8 (95% CI, 2.0–6.9) in 
current smokers, in comparison with the men 
who had never smoked
Voigt et al. 
1994






Diagnosis of RA •	Women with ≥20 pack-years of smoking, RR 





and 71 same-sex 
dizygotic twin pairs 




Diagnosis of RA •	Strong association between ever smoking and 
RA in the monozygotic pairs, OR = 12.0 (95% CI, 
1.78–513), with a similar trend observed in the 
dizygotic pairs, OR = 2.5 (95% CI, 0.92–7.87)
Symmons et 
al. 1997





Diagnosis of RA •	History of having ever smoked was associated 




•	377,481 women Never, ever, pack-
years
Diagnosis of RA, 
RF status
•	 In age-adjusted analysis, compared with women 
who never smoked, the RR of developing RA was 
1.01 (95% CI, 0.95–1.08) among past smokers 
and RR = 1.22 (95% CI, 1.16–1.28) among 
current smokers
Uhlig et al. 
1999
•	361 recently 
diagnosed RA cases 




Diagnosis of RA, 
RF status
•	Current smoking was an overall risk factor, OR 
= 1.46 (95% CI, 1.10–1.94), in men, OR = 2.38 
(95% CI, 1.45–3.92), especially in men with 








Diagnosis of RA •	Compared with women who had never smoked, 
women who were current smokers, RR = 2.0 
(95% CI, 1.3–2.9) or who had quit ≤10 years 
before study baseline, RR = 1.8 (95% CI, 1.1–3.1) 
were at increased risk of RA, but women who 
had quit >10 years before baseline were not at 
increased risk, RR = 0.9 (95% CI, 0.5–2.6)
Padyukov et 
al. 2004







•	RR of RF-seropositive RA = 2.8 (95% CI, 1.6–4.8) 
in never smokers with SE genes, RA = 2.4 
(95% CI, 1.3–4.6) in current smokers without 
SE genes, and RA = 7.5 (95% CI, 4.2–13.1) in 
current smokers with SE genes
•	Smokers carrying 2 SE genes, RR of RF-
seropositive RA = 15.7 (95% CI, 7.2–34.2)
•	 Interaction between smoking and SE genes was 
significant with AP = 0.4 (95% CI, 0.2–0.7) for 
smoking and any SE, AP = 0.6 (95% CI, 0.4–0.9) 
for smoking and 2 SE
Other Specific Outcomes     S-401
The Health Consequences of Smoking —50 Years of Progress
Table 10.14S Continued
Study Design/ population Tobacco exposure Outcome Findings
Costenbader 
et al. 2006
•	680 women with 





Diagnosis of RA •	RR of RA was significantly elevated among 
current, RR = 1.43 (95% CI, 1.16–1.75) and 
past smokers, RR =1.47 (95% CI, 1.23 1.76), 
compared with never smokers
•	Risk of RA was significantly elevated with 10 
pack-years or more of smoking and increased 












in serum and 
BAL cells
•	 In smokers, increased risk of anti-ccp positive 
RA in SE-negative individuals, RR = 1.5 (95% CI, 
0.8–2.6), 1 SE copy increased RR = 6.5 (95% CI, 
3.8–11.4) and 2 SE copies increased RR = 21.0 
(95% CI, 11.0–40.2)
•	 In nonsmokers, RR was 3.3 (95% CI, 1.8–5.9) 










Diagnosis of RA •	Tobacco smoking, OR = 1.65 (95% CI, 1.03–
2.64; for >20 vs. 0 pack-years) was selectively 
associated with risk of anti-CCP-positive RA
Costenbader 
et al. 2008
•	437 women with 





Diagnosis of RA •	PTPN22 was associated with increased RA risk, 
pooled OR in multivariable dominant model = 
1.46 (95% CI, 1.02–2.08)
•	Significant multiplicative interaction between 
PTPN22 and smoking for more than 10 pack-
years was observed (P = 0.04). 
Karlson et 
al. 2010








•	Strong additive interaction, AP = 0.50 (p <0.001) 
and significant multiplicative interaction (p = 
0.05) were found between heavy smoking and 
any HLA-SE in seropositive RA risk
•	Highest risk was in heavy smokers with double 
copy HLA-SE, OR = 7.47 (95% CI, 2.77– 20.11)
Keenan et 
al. 2010








null, and alleles 
for GSTP1 and 
HMOX1 
•	For the risk of all RA, multiplicative (p  = 0.05) 
and additive, AP = 0.53 (P = 0.0005) interactions 
between the GSTT1-null polymorphism and ever 
smoking and multiplicative interactions (P = 
0.05) between HMOX1 and ever smoking were 
observed
Mikuls et al. 
2010
•	605 AA RA cases 




SE status •	Significant additive interaction between SE 
status and heavy smoking (≥10 pack-years) in RA 
risk, AP =0.58 (p = 0.007) with an AP = 0.47 (p = 




•	290 incident RA 
cases
Current smoker, 
smoker for >10 
years, smoker of 
>20 cigarettes/
day
Diagnosis of RA •	Current smoking associated with RA, OR = 1.79 
(95% CI, 1.32–2.42)
Surgeon General’s Report
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Table 10.14S Continued
Study Design/ population Tobacco exposure Outcome Findings
de Hair et 
al. 2012
•	55 persons at risk 
for developing RA 




Diagnosis of RA •	Smoking was associated with development of 
RA, HR = 9.6 (95% CI, 1.3–73.0)
Mikuls et al. 
2012
•	727 AA early RA (<2 
yrs) cases compared 











•	Significant additive interactions between heavy 
smoking and NAT2 SNPs rs9987109 (Padditive = 
0.000003) and rs1208 (Padditive = 0.00001)
•	Attributable proportion due to interaction 








•	High (>100 IU/mL) RF positivity was associated 
with 10-year risk of developing RA, HR = 39 
(95% CI, 18–85), especially if smoker 
Too et al. 
2012
•	1,076 RA cases and 
1,612 matched 
controls




•	SE alleles and smoking were associated with 
increased risk of developing anti-ccp positive RA, 
OR SE alleles = 4.7 (95% CI, 3.6–6.2)
•	OR smoking = 4.1 (95% CI, 1.9–9.2)
Bergström 
et al. 2013
•	172 RA cases 
compared to age 








Diagnosis of RA •	Ever smoking increased likelihood of having RA, 
OR = 2.02 (95% CI, 1.31–3.12)
Note: AA = African American; Anti-ccp = anticyclic citrullinated peptide; AP = attributable proportion; BAL = bronchoalveolar lavage; 
CI = confidence interval; HR = hazard ratio; IU/mL = international units per milliliter; OR = odds ratio; RF = rheumatoid factor;  
RR = relative risk; SE = standard error; SNPs = single nucleotide polymorphisms.
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Saag et al. 
1997
•	336 RA patients Current, 
former, never, 
pack-years
Larsen score, RF 
positivity, and 
presence of nodules
•	Pack-years of cigarette smoking was significantly 
associated with RF positivity, radiographic 
erosions, and nodules 








RF values, Larsen 
score, nodules
•	RF concentration and nodule formation were 
linearly related to the number of years smoked
•	Nonlinear relationships were found between 
smoking and Larsen score and pulmonary illness
Mattey et al. 
2002





HAQ score, Larsen’s 
score
•	Ever having smoked was associated with a worse 
radiographic and functional outcome than was 
never having smoked
•	Both past and current smoking were associated 
with increased disease severity
Turesson et al. 
2003
•	609 RA patients Ever, never Presence of extra-
articular disease
•	Main predictor of severe extra-articular 
manifestations was smoking at RA diagnosis 
Papadopoulos 
et al. 2005






score, presence of 
nodules
•	Smoker patients had higher DAS-28, and higher 
Larsen’s score as compared to nonsmokers at 
diagnosis and at follow-up
•	Smokers more frequently had rheumatoid 
nodules than the ex-smokers and nonsmokers
Nyhall-Wahlin 
et al. 2006





Presence of nodules •	Strong association between smoking and 
rheumatoid nodules in early seropositive 
rheumatoid arthritis
Finckh et al. 
2007
•	2,004 RA patients Nonsmoker, 
smoker, pack-
years
Ratingen score •	Radiographic joint damage progressed at a 
similar rate in current smokers and nonsmokers
•	Smoking intensity was associated with a 
significant inverse dose-response
•	Heavy smokers (>1 pack-day) progressed 
significantly less than nonsmokers or moderate 
smokers









IgA RF serum 
concentration, 
nodules
•	Current smokers were approximately twice as 
likely as never smokers to have higher IgA-RF 
concentrations and nodules 
Kim et al. 
2008c





•	Smoking was closely associated with extra-
articular manifestation
Naranjo et al. 
2010




•	Ever smokers were more likely to be RF-positive
•	Rheumatoid nodules were more frequent in ever 
smokers
•	Erosive arthritis and extra-articular disease were 
similar in all smoking categories
•	Mean DAS28 was similar in nonsmokers vs. 
those who had ever smoked
Surgeon General’s Report














•	No difference in disease activity between smokers 
and nonsmokers













•	No difference in EULAR responses between 
smoking groups but high risk of cardiovascular 
mortality and morbidity in smokers with RA
Moura et al. 
2012




•	Current smoking correlated with presence of 
extra-articular disease
Söderlin et al. 
2013




•	No association between secondhand exposure 
and disease activity
Note: DAS-28 = disease activity scale 28; EULAR = European League Against Rheumatism; HAQ = health assessment questionnaire; 
IgA = immunoglobulin A; RF = rheumatoid factor; RR = relative risk; SE = standard error.
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Table 10.16S Studies on the association between smoking and rheumatoid arthritis (RA) treatment response
Study Population Tobacco exposure Outcome Findings
Hyrich et al. 
2006
•	2,879 patients receiving 
infliximab or etanercept
Current smoker EULAR disease 
response
•	Current cigarette smoking was associated 
with lower response rate among patients 




•	5,043 RA patients on 
leflunomide 
Smoking history Leflunomide 
lung injury
•	Smoking is a risk factor for developing 
leflunomide-associated lung injury, OR = 3.12
Westhoff et 
al. 2008
•	896 early RA patients Never, quit before 
RA onset, smoked 
continuously, 
pack-years
Drug need •	Current RF+ smokers had taken more 
DMARD combinations (35.8%) or biologics 
(14.9%) than RF+ previous smokers (29.9% 
and 11.2%, respectively) and RF+ never 
smokers (20.3% and 8.1% respectively), p = 
0.022 for DMARDs and p = 0.105 for biologics
Mattey et al. 
2009







•	 Increasing trend of no response with 
increasing pack-years at 3 and 12 months (p 
trend = 0.008 and 0.003, respectively)
•	DAS28 was inversely associated with number 
of pack-years (r = −0.28; p = 0.002)
Abhishek et 
al. 2010
•	395 RA patients 







•	Current smoking reduced the chance of 
achieving at least a moderate response on the 
EULAR response criteria when compared with 




•	535 early RA patients 






•	Compared with never smokers, current 
smokers were less likely to achieve a good 
response at 3 months following the start of 
MTX (27% vs. 36%; P = 0.05) and at 3 months 
following the start of anti-TNF drugs (29% vs. 
43%; p = 0.03)
Canhão et al. 
2012
•	617 RA patients 
starting their first anti-
TNF drug
Ever, never EULAR disease 
response
•	Smoking was negatively associated with good 
disease response, OR = 0.98 (95% CI, 0.55–
1.71; p = 0.009)
Khan et al. 
2012




DAS28 score •	Never smokers had the highest falls in DAS28 
scores (mean 2.72, SD 0.94)
•	Previous smokers had fewer falls (mean 1.49, 
SD 0.92)
•	Current smokers the least falls (mean 0.63, 




•	934 RA patients 







•	Current smoking was predictive of poor 
response, OR = 0.53 (95% CI, 0.32–0.87; p = 
0.012)
Note: AOR = adjusted odds ratio; CI = confidence interval; DAS-28 = disease activity scale 28; DMARD = Disease-Modifying 
Antirheumatic Drug; EULAR = European League Against Rheumatism; MTX = methotrexate; OR = odds ratio; pack-years = the 
number of years of smoking multiplied by the number of packs of cigarettes smoked per day; RF = rheumatoid factor; SD = standard 
deviation; TNF = tumor necrosis factor.
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Table 10.17S Studies on the association between smoking and systemic lupus erythematosus (SLE) risk
Study Population Tobacco exposure Outcome Findings







•	Risk of SLE was significantly increased for 









•	Age-adjusted RR of SLE showed no relation to 
smoking status: compared with never smokers, 
current smokers RR = 1.09 (95% CI, 0.66–1.80) 
and past smokers RR = 0.91 (95% CI, 0.54–1.55)






•	Current smokers had a significantly increased 
risk of development of SLE compared with never 
smokers, OR = 1.95 (95% CI, 1.14–3.31)






•	No association with smoking history and risk of 
developing SLE, OR = 1.1 (95% CI, 0.7–1.7) for 
current smokers, or former smokers, OR = 0.6 
(95% CI, 0.4–1.0), compared to never smokers
Ghaussy et al. 
2001






•	Smoking before SLE diagnosis and ex-smoking 
before SLE diagnosis significantly increased the 
risk of development of SLE, OR = 6.69 (95% CI, 
2.59–17.28; p <0.001) OR = 3.62 (95% CI, 1.22–
10.70; p = 0.02, respectively)
Bengtsson et al. 
2002







•	Suggested association with increased SLE risk 
was seen for smoking, OR = 1.8 (95% CI, 0.9–3.6)
Formica et al. 
2003










•	 IRR for current and past smoking = 1.6 (95% CI, 
0.8–3.3)
•	Risk was greater for women who began smoking 
before age 19 years, IRR = 1.9 (95% CI, 1.0–3.6)







•	Higher smoking prevalence noted in DLE cases 
(84.2%) than controls (33.5%), and the adjusted 
OR was 14.4 (95% CI, 6.2–33.8; multiple logistic 
regression, p <0.01)






•	Smoking status not associated with SLE risk, OR 
= 1.2 (95% CI, 0.7–2.3) for former smokers and 
OR = 0.8, (95% CI, 0.6–1.2) for current smokers, 
compared to never smokers
Kiyohara et al. 
2012a








•	Compared with nonsmoking, current smoking 
was significantly associated with increased risk of 
SLE, OR = 3.06 (95% CI, 1.86–5.03) 
Kiyohara et al. 
2012b












•	Smokers with CC genotype of CYP1A1 rs4646903 
were significantly associated with increased risk 
of SLE, OR = 9.72 (95% CI, 2.73–34.6)
•	Smokers with combined CYP1A1 rs4646903/
GSTM1 ‘at-risk’ genotype were significantly 
associated with increased risk of SLE, OR = 17.5 
(95% CI, 3.20–95.9)
Other Specific Outcomes     S-407
The Health Consequences of Smoking —50 Years of Progress
Table 10.17S Continued
Study Population Tobacco exposure Outcome Findings
Ekblom-Kullberg 
et al. 2013
•	223 SLE cases 
•	1,538 controls





•	 In women with a history of daily smoking for 
more than 1 year, OR for SLE = 1.45 (95% CI, 
1.07–1.97), in current daily smokers as compared 
to never smokers, OR = 1.55 (1.00–2.40), and 
in ex-smokers vs. never smokers OR = 1.80 
(1.15–2.83)
•	Number of men with SLE, who smoked >100 
cigarettes during their lifetime was higher than 
in male controls (p = 0.026)
Note: CI = confidence interval; DLE = discoid lupus erythematosus; IRR = incidence rate ratio; OR = odds ratio; RR = relative risk.
Surgeon General’s Report
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Table 10.18S Studies on the association between smoking and systemic lupus erythematosus (SLE) severity  
and manifestations








Development of ESRD •	 Smoking status at onset of nephritis was 
strongly associated with differences in time 
to development of ESRD with a median 
time of developing ESRD at 146 months for 
smokers and 273 months for nonsmokers






SLEDAI •	 Current smokers demonstrated significantly 






Never, ever Presence of thrombotic 
event
•	 Smoking is a significant risk factor for 
thrombosis








•	 Significantly higher risk of dsDNA 
seropositivity in current smokers than 
former or never smokers




Never, ever Presence of thrombotic 
event
•	 Smoking was a significant risk factor for 
thrombosis








•	 Current smoking is associated with scarring 
and active lupus rash






Health related quality 
of life
•	 Smokers more likely to have poor 
health related quality of life compared to 
nonsmokers
Piette et al. 
2012





response to treatment, 
quality of life
•	 Current smokers with SLE had worse 











•	 Current smoking was associated with active 
rash, as recorded by the SLEDAI-2K, OR 
= 1.63 (95% CI, 1.07–2.48) for current vs. 
noncurrent smokers, and OR = 1.68 (95% 
CI, 1.08–2.60) for current vs. never smokers
•	 Ever smoking was associated with the 
presence of cutaneous ACR criteria, OR = 
1.50 (95% CI, 1.22–1.85)
•	 Association driven by discoid rash, 
OR = 2.36 (95% CI, 1.69–3.29) and 
photosensitivity, OR = 1.47 (95% CI, 
1.11–1.95)
•	 Higher pack-years was associated with the 
presence of active rash among current 
smokers, RR/5 pack-years = 1.17 (95% CI, 
1.06–1.29).
Note: ACR = American College of Radiology; CI = confidence interval; CLE = cutaneous lupus erythematosus;  
dsDNA = double-stranded DNA; ESRD = end stage renal disease; pack-years = the number of years of smoking multiplied by the 
number of packs of cigarettes smoked per day; OR = odds ratio; RR = relative risk; SLEDAI = systemic lupus erythematosus disease 
activity index.
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Table 10.19S Studies on smoking and systemic lupus erythematosus (SLE) treatment response
Study Population Tobacco Exposure Outcome Findings
Wahie et 
al. 2011
•	200 cases with DLE 




Clinical response to 
hydroxychloroquine
•	No significant difference in response rate 
between nonsmokers compared with smokers 











•	A significant difference (p <.0002) in 
antimalarial response rate was observed for 
smokers (40%) vs. nonsmokers (90%)
Note: CI = confidence interval; CLE = cutaneous lupus erythematosus; DLE = discoid lupus erythematosus; ESRD = end stage renal 
disease; OR = odds ratio; pack-years = the number of years of smoking multiplied by the number of packs of cigarettes smoked per 
day; SCLE = subacute cutaneous lupus erythematosus.
Surgeon General’s Report
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Other Specific Outcomes     S-427
The Health Consequences of Smoking —50 Years of Progress
Table 10.21S Characteristics of the studies on the effects of former smoking on Crohn’s disease or ulcerative colitis
Study Design/Population Effect estimate (CI)
Adjustments for current smoking 
effect estimate




















•	Former smoking: 3.50 (1.50–8.00) Age, gender, education or social class, 







•	Former smoking: 0.82 (0.04–15.37)






•	Former smoking: 3.58 (1.82–7.06)






•	Former smoking: 1.90 (0.80–4.30) Age, gender, location, region or center










•	 Incident Crohn’s disease
•	23 cases
•	 Italy
•	Former smoking: 1.03 (0.26–4.19)






•	Former smoking: 2.06 (0.47–8.96)






•	Former smoking: 0.81 (0.44–1.50)






•	Former smoking: 0.64 (0.21–1.93)
Surgeon General’s Report
S-428     Chapter 10 Tables Supplement
Study Design/Population Effect estimate (CI)
Adjustments for current smoking 
effect estimate
Corrao et al. 
1998
•	Case control 
•	 Incident Crohn’s disease
•	147 cases
•	 Italy







•	Former smoking: 2.59 (0.92–7.31)






•	Former smoking: 1.19 (0.75–1.90) Age, gender, education or social class, 







•	Former smoking: 0.23 (0.07–0.74) Age, gender, education or social class, 
tonsillectomy or appendectomy, 
oral contraceptives or hormone 
replacement therapy






•	Former smoking: 4.35 (0.39–30.41)






•	Former smoking: 0.89 (0.48–1.64)
Carlens et al. 
2010
•	Prospective cohort
•	 Incident Crohn’s disease
•	228 cases
•	Sweden 
•	Former smoking: 1.30 (1.00–1.80) Age, location, region or center, other






•	Former smoking: 0.91 (0.65–1.27) Age, gender, race or ethnicity, 
education or social class, family history 







•	Former smoking: 0.84 (0.57–1.23)






•	Former smoking: 0.63 (0.31–1.29) Age, gender, race or ethnicity, location, 
region or center, tonsillectomy or 
appendectomy, oral contraceptives or 








•	Former smoking: 1.37 (0.39–4.79)
Table 10.21S Continued
Other Specific Outcomes     S-429
The Health Consequences of Smoking —50 Years of Progress
Study Design/Population Effect estimate (CI)
Adjustments for current smoking 
effect estimate
Vessey et al. 
1986
•	Prospective cohort




•	Former smoking: 0.79 (0.10–6.52)







•	Former smoking: 2.50 (0.51–12.20) Age, gender

















Age, oral contraceptives or hormone 
replacement therapy







•	Former smoking: 1.65 (0.75–3.61)
Higuchi et al. 
2012
•	Prospective cohort 




•	Former smoking: 1.35 (1.05–1.73) Age, gender, body mass index, 
oral contraceptives or hormone 
replacement therapy
Harries et al. 
1982
•	Case Control











•	Former smoking: 1.16 (0.77–1.76) Age, gender, location, region or center













•	Former smoking: 9.92 (1.89–51.93)
Table 10.21S Continued
Surgeon General’s Report
S-430     Chapter 10 Tables Supplement
Study Design/Population Effect estimate (CI)
Adjustments for current smoking 
effect estimate













•	Former smoking: 2.70 (1.50–4.90) Age, gender, education or social class, 







•	Former smoking: 0.89 (0.37–2.16) Age






•	Former smoking: 1.17 (0.67–2.04)






•	Former smoking: 2.30 (1.40–3.90) Age, gender, location, region or center






•	Former smoking: 2.30 (0.50–10.00) Age, gender, education or social class













•	Former smoking: 0.76 (0.35–1.63) Age, gender, location, diet, other






•	Former smoking: 1.31 (0.68–2.52) Age, gender, education or social class






•	Former smoking: 1.50 (0.70–3.40) Age, other






•	Former smoking: 0.86 (0.55–1.32) Age, gender
Table 10.21S Continued
Other Specific Outcomes     S-431
The Health Consequences of Smoking —50 Years of Progress
Study Design/Population Effect estimate (CI)





•	 Incident ulcerative colitis
•	41 cases 
•	 Italy 





























•	Former smoking1.37 (0.49–3.83) Age, gender, education or social class, 
other






•	Former smoking: 1.17 (0.36–3.78)





















•	Former smoking: 0.88 (0.80–0.97) Age, gender, race or ethnicity, 
tonsillectomy or appendectomy, former 
smoking
Corrao et al. 
1998
•	Case control
•	 Incident ulcerative colitis
•	457 cases 
•	 Italy 
•	Former smoking: 3.00 (2.10–4.30) Age, location, region or center, 








•	Former smoking: 2.54 (1.27–5.08)
Table 10.21S Continued
Surgeon General’s Report
S-432     Chapter 10 Tables Supplement
Study Design/Population Effect estimate (CI)
Adjustments for current smoking 
effect estimate






•	Former smoking: 1.73 (1.14–2.65) Age, gender, education or social class, 







•	Former smoking: 1.03 (0.63–1.67) Age, gender, education or social class, 
tonsillectomy or appendectomy, 
oral contraceptives or hormone 
replacement therapy






•	Former smoking: 3.45 (1.62–7.35)






•	Former smoking: 4.38 (1.34–12.66)






•	Former smoking: 1.90 (1.10–3.30) Age, gender, race or ethnicity, location, 
region or center, family history of 
inflammatory bowel disease






•	Former smoking: 6.24 (1.75–22.20) Age, gender, family history of 
inflammatory bowel disease, 
tonsillectomy or appendectomy, 
alcohol, coffee or tea, diet





•	United States  
•	Former smoking: 1.50 (0.86–2.64)






•	Former smoking: 1.10 (0.68–1.79)
Carlens et al. 
2010
•	Prospective cohort
•	 Incident ulcerative colitis
•	427 cases 
•	Sweden 
•	Former smoking: 1.50 (1.20–1.80) Age, location, region or center, other






•	Former smoking: 1.53 (1.14–2.25) Age, gender, race or ethnicity, 
education or social class, family history 







•	Former smoking: 1.73 (1.33–2.25)
Table 10.21S Continued
Other Specific Outcomes     S-433
The Health Consequences of Smoking —50 Years of Progress
Study Design/Population Effect estimate (CI)
Adjustments for current smoking 
effect estimate






•	Former smoking: 0.94 (0.51–1.74) Age, gender, race or ethnicity, location, 
region or center, tonsillectomy or 
appendectomy, oral contraceptives or 
hormone replacement therapy, coffee 
or tea, diet
Vessey et al. 
1986
•	Prospective cohort 




•	Former smoking: 0.47 (0.18–1.25







•	Former smoking: 3.59 (0.64–20.00 Age, gender, oral contraceptives or 
hormone replacement therapy
Boyko et al. 
1994
•	Case control 




•	Former smoking: 2.20 (1.40–3.44
Higuchi et al. 
2012
•	Prospective cohort 




•	Former smoking: 1.56 (1.26–1.93 Age, gender, body mass index, 
oral contraceptives or hormone 
replacement therapy





•	Former smoking: 1.78 (0.71–4.45
Source: Epidemiology Group of the Research Committee of Inflammatory Bowel Disease in Japan 1994 (EGRCIBD).





General Morbidity and All-Cause Mortality
Table 11.1S Studies on the association between smoking and all-cause mortality     S-437
Table 11.2S Studies on the association between smoking and poor general health     S-439
Table 11.3S Studies on the association between smoking and relative risk of poor functional status     S-441
Table 11.4S Studies on the association between smoking and SF-36 or SF-12 scores     S-444
Table 11.5S Studies on the association between smoking and other measures of health and function     S-446
Table 11.6S Studies on the association between smoking and hospitalizations     S-448
Table 11.7S Studies on the association between smoking and outpatient visits     S-450
Table 11.8S Studies on the association between smoking and nursing home stays     S-451
Table 11.9S Studies on the association between smoking and costs     S-452
Table 11.10S Annual per capita spending on health care, by smoking status and age group (2008 dollars)     S-453
Table 11.11S Studies on the association between smoking and workplace absenteeism (days absent)     S-454
Table 11.12S Studies on the association between smoking and relative risk of workplace absenteeism     S-456

General Morbidity and All-Cause Mortality     S-437






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































General Morbidity and All-Cause Mortality     S-439

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































General Morbidity and All-Cause Mortality     S-441
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General Morbidity and All-Cause Mortality     S-447















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































General Morbidity and All-Cause Mortality     S-449
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General Morbidity and All-Cause Mortality     S-453
The Health Consequences of Smoking —50 Years of Progress
Table 11.10S Annual per capita spending on health care, by smoking status and age group (2008 dollars*)
18–24 years 25–44 years 45–64 years 65–74 years ≥75 years
People who have never smoked 1,870 2,570 5,040 7,790 9,810
Current or former smokers 2,010 2,940 6,170 9,230 11,580
 Current smokers 2,010 2,850 5,540 7,940 8,750
Former smokers
     For <5 years 2,000 3,090 7,650 11,250 15,530
     For 5–14 years n.a. 2,920 6,580 9,760 12,280
     For ≥15 years n.a. 3,330 6,290 9,330 11,770
Source: Congressional Budget Office 2012. 
Note: n.a. = not available (because of a lack of data to produce precise estimates). Based on data for 2000 to 2008 from the Medical 
Expenditure Panel Survey and for 1998 to 2007 from the National Health Interview Survey.
*The numbers shown here are rounded to the nearest $10.
Surgeon General’s Report
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